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SUMMARY
The role of the extracellular matrix in the liver is 
complex, and. this thesis will study both the structure 
and role of normal hepatic extracellular matrix, and how 
these are affected in liver disease. In order to do 
this, it was necessary to develop new techniques as well 
as using methods already available.
I a  Chapter 1, the basic structure of the liver is 
described. It also identifies the different types of 
liver cells which are present, and their known 
functions. Liver injury is examined in Chapter 2 and 
this covers both the possible responses of the hepatic 
cells to injury, and the patterns of injury found in 
different disease entities.
Chapter 3 identifies the different component groups of 
the extracellular matrix, and their general structure 
and function. The largest of these groups is the
collagen family, and this is studied in greater detail 
in Chapter 4. The remaining components of the
extracellular matrix are individually described in 
Chapter 5.
The previous three chapters looked at the components 
found in all extracellular matrices, and in Chapter 6 
the hepatic extracellular matrix is described in greater 
detail. This chapter covers both the composition of 
the extracellular matrix and the cells which are 
believed to be responsible for their synthesis. It
summarises the knowledge of the hepatic extracellular 
matrix that was available at the beginning of this 
study.
In Chapter 7, the different techniques available for the 
ultrastructural examination of liver tissue are 
described and compared. This chapter also includes the 
development of novel techniques for the ultrastructural 
study of the hepatic extracellular matrix. The
materials and methods are detailed in Chapter 8, 
including the types of liver tissue used.
The techniques described in Chapters 7 and 8 were used 
to map the distribution of the extracellular matrix in 
normal human liver in Chapter 9. It was necessary to 
identify the normal distribution of the extracellular 
matrix in a number of biopsies in order to identify any 
changes in the distribution which may occur during 
disease processes. A range of components were
examined, including collagen types I, III, IV, V, and 
VI, laminin, vitronectin and fibronectin. At this
stage, it was decided which antibodies used in the study 
of normal liver were suitable for continuing studies in 
diseased liver.
It was decided to examine the effects of liver disease 
on the distribution of collagen types I, III, IV, and
VI, as well as on fibronectin. These are illustrated 
in Chapter 10.
In the last chapter, a number of points arising from 
this study are discussed. These include the validity 
of the techniques used, technical problems with the 
immunolabelling techniques used, the altered
distribution of the extracellular matrix in diseased 
liver, the novel description of type VI collagen 
distribution and the possible cellular origin of the 
extracellular matrix proteins. Finally, the overall, 
and extremely complex role of the extracellular matrix 
is examined, both in normal and diseased liver.
The most important aspects of this work fall into two 
categories. The first is the development of the 
ultracryomicrotomy techniques which were necessary in 
order to carry out the immunocytochemical studies. 
Once this part of the work had been completed, it was 
possible to study new aspects of the hepatic 
extracellular matrix in great detail, including the 
distribution of type VI collagen, and the development of 
basement membranes in the space of Disse .
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1.1 Liver architecture
The liver is one of the most important organs in the 
body, and has several major functions including the 
processing of nutrients present in portal blood, removal 
and degradation of toxins such as bacterial endotoxin and 
endogenous substances (e.g. hormones), and the phagocytosis 
of immune complexes and other particulate matter.
The structure of the liver reflects the complex range 
of functions and metabolic demands placed upon it. The 
microcirculatory architecture allows almost free access of 
blood plasma to the hepatocytes. In the adult liver of
most species, the hepatocytes form plates, or cords, of 
single cell thickness. The capillaries which lie adjacent 
are known as the sinusoids, and are lined by endothelial 
cells. The sinusoids are specialised capillaries in that 
not only are they fenestrated but they lack any 
identifiable basement membrane when examined
ultrastructurally* Evidence that some form of basement 
membrane is present has come from immunohistochemical 
studies which have purported to demonstrate the presence of 
basement membrane components at that site, i.e. type IV 
collagen and laminin forming an amorphous material (Hahn et 
al, 1980; Griffiths, Keir and Burt, 1991). This is however 
controversial and will be referred to later in the text. 
The structure of the endothelium imparts upon the sinusoid 
its porosity, this is important for facilitating transport 
of materials between the sinusoidal lumen and the 
hepatocytes. The sinusoidal blood flow is of low
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(a) Structure of the acinus
1. Acinar agglomerate
2. Three complex acini
3. Simple acini
4. Acinuli
The acinar agglomerate is supplied by a portal vein and 
hepatic artery branch. This sub-divides into three
branches, each supplying a complex acinus.
(b) Comparison of acinar structure and lobular structure
PS - portal space ThV - terminal
hepatic vein
1, 2, 3 - microcirculatory zones
outline of classic lobule
(c) Comparison of terminologies
Lobular Acinar
Central, centrilobular, 
centrizonal
Perivenular, 
acinar zone 3
Mid-zonal Acinar zone 2
Peripheral, periportal 
acinar zone 1
Periportal,
Multilobular Multiacinar
Panlobular Panacmar
Central/central 
(complex)
Peri-acinar
Central/portal Peri-acinar
(simple)
peripheral acinar
Portal/portal Portal/portal
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Figure 1.1 (a)
'NODAL POINT 
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OF MALL
Figure 1.1 (b)
Illustration reproduced from Pathology of the Liver, 
2nd edition
(Eds MacSween RMN, Anthony PP and Scheuerpj.)
pressure and is derived from splanchnic blood from the
portal vein, and blood from the hepatic artery. The
splanchnic blood contains absorbed nutrients and toxins, 
while the hepatic artery contains mainly nutrients. The 
sinusoids carry the blood through the liver, and outflow is 
via the hepatic vein branches.
Several groups have attempted to define the
functional unit of the liver. The concept of the liver 
lobule was defined by Elias in 1949. It is a polyhedral 
structure and is usually represented as a hexagon with a 
terminal hepatic vein at the centre, and portal tracts 
lying at the corners of the lobule (see Fig 1.1). The
liver increases in size by growth and division of the liver 
lobules. This involves an increase in the number and size 
of hepatocytes and a reduction in the size of the liver 
sinusoids. An alternative structural arrangement of the 
liver is the so-called acinus. Rappaport et al described 
this as the microcirculatory unit of the liver which can be 
split arbitrarily into three zones (Fig 1.1). Zone 1 is 
the periportal zone, zone 2 is the mid-zone, and zone 3 is 
the perivenular zone. These zones are often used to
describe the location of cells or lesions within the liver, 
and this is the definition which will be used throughout 
this study.
There is functional heterogeneity among the three 
zones, and this may be due to the unidirectional flow of 
blood in the liver. Hepatocytes in zone 1 receive the 
highest concentration of solutes in the blood, whereas 
blood entering zone 3 has already been modified by the
hepatocytes in zones 1 and 2. Examples of zonal
heterogeneity include hepatocyte uptake of galactose, this 
being highest in zone 1 (Goresky, Bach and Nadeau, 1973). 
It has been suggested that sinusoids within zone 1 are 
narrow and tortuous to allow slow passage of solutes and 
maximum interaction with hepatocytes, while zone 3 sinuoids 
are straighter and wider to allow easy drainage of the 
acinus (Miller et al, 1979). Cytochrome P-450 isoenzymes, 
one of the key hepatic drug metabolising systems are found 
in increasing amounts from zone 1 to zone 3 (Gumucio and 
Chianale, 1980). The distribution of these enzymes means 
that zone 3 also contains the highest concentration of 
toxic metabolites. This is consistent with the
susceptibility of zone 3 hepatocytes to toxic injury. The 
metabolism of glucose also has a zonal distribution (Agius 
et al, 1990). Gluconeogenesis predominates in the
periportal zone as does glycogen formation. The same
cells are active in glycogenolysis when the appropriate 
hormonal signal is received. The cells in zone 3 are most 
active in glycolysis. The location of the enzymes
involved in these metabolic processes is also zonal. When 
rat liver is perfused in a retrograde direction the 
metabolic zonation is reversed suggesting that the 
hepatocytes can quickly alter the expression of their 
enzymes if there is a change in physiological conditions.
The liver is encapsulated in a fibrous sheath called 
Glissons capsule. There are two tracts of connective 
tissue within the liver. The larger one extends into the 
liver at the porta hepatis, and constitutes the fibrous
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tissue of the portal tracts throughout the liver. It
contains the afferent blood vessels, bile ducts nerves and 
lymphatics. The smaller tract surrounds the hepatic
veins. The two tracts do not connect, and are physically 
separated by the parenchyma, although the vascular 
structures do connect by way of the sinusoids.
1.2 Cellular components of mammalian liver
Hepatocytes (also referred to as the parenchymal 
cells) represent 60% of the liver cells. Because they are 
larger in size than the other cell types which are 
collectively referred to as the non-parenchymal cells, they 
occupy almost 80% of the liver by volume. Five percent
of liver volume is taken up by the sinusoidal cells, which 
comprise four distinct cell populations: sinusoidal
endothelial cells, fat-storing cells (also called Ito 
cells, perisinusoidal cells or lipocytes), Kupffer cells 
(hepatic macrophages) and pit cells (large granular 
lymphocytes, or liver associated lymphocytes). The
remainder of the liver is composed of (1) other cell types 
(vascular endothelium, portal tract fibroblasts, bile duct 
epithelium, neurones and associated Schwann cells), (2) 
extracellular spaces such as the sinusoidal lumen and the 
space of Disse, and (3) the extracellular matrix.
1.3 Hepatocytes.
The hepatocytes are large polygonal epithelial cells, 
which have three distinct membrane domains. These are: 
(1) the basolateral surface with microvilli,
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(perisinusoidal and pericellular), (2) the straight or 
contiguous domain, and (3) the bile canalicular surface, 
where the adjacent cell membranes form narrow channels, the 
canaliculi, for the transport of bile. The plasma
membrane of the hepatocyte contains a relatively large 
amount of glycosylated protein and lipids and a high 
cholesterol:phospholipid ratio (Arias,1988). The different 
domains have characteristic features. The sinusoidal
surface is involved in phagocytosis and endocytosis, as 
indicated by the formation of clathrin-coated vesicles and 
the presence of a wide range of membrane receptors. The 
canalicular membrane makes up about 15% of the total 
surface and has different receptors to the basolateral 
surfaces. Bile acid and other organic anions secreted by 
the liver cells are transferred into the canaliculus, and 
its transport along the canaliculus may in part be due to 
the contractile capability of the canalicular membrane. 
The hepatocyte contains a large nucleus, and has a well 
developed endoplasmic reticulum and Golgi apparatus, 
indicating active protein synthesis. It also contains 
large numbers of mitochondria.
There are a few metabolic processes which are unique 
to hepatocytes, such as
i. The urea cycle, which regulates ammonia and amino 
acid metabolism.
ii. The regulation of cholesterol metabolism
iii. Formation and conjugation of bilirubin.
iv. Formation of glycogen rosettes.
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In contrast, there are a number of processes where the 
hepatocyte is the principal, but not exclusive site i.e. 
plasma protein synthesis.
1.4 Non-parenchymal cells.
1.4.1 Bile Duct Epithelial cells.
Bile ducts are lined by epithelial cells, which have 
smaller nuclei and mitochondria than hepatocytes. They are 
tall columnar cells with basally situated nuclei, and have 
a basement membrane. In the small intrahepatic bile ducts, 
the cells may be cuboidal. They can also be distinguished 
from hepatocytes because they lack the enzyme glucose-6- 
phosphatase which is characteristic of hepatocytes. They 
do contain gamma-glutamyl transpeptidase. Bile duct
epithelial cells have a characteristic cytokeratin profile, 
with types 7, 8, 18 and 19 all present (Van Eyken et al,
1987 ) .
1.4.2 Fat-storing cells.
These cells were first described morphologically in 
1869 by Boll, but it was not until 1973 that Ito described 
them as a separate cell type. Fat-storing cells are
localised underneath the endothelial lining, within the 
space of Disse, and processes of the cell can be found in 
gaps between adjacent hepatocytes. They are identified 
ultrastructurally by a range of features. These include 
fat droplets in the cytoplasm, which range in both size and 
number between species (Ito, 1973). The droplets may be 
up to 2^ /m in diameter (Yamamoto and Ogawa, 1983), and
display a rapidly fading green auto-fluorescence with light 
of wavelength of 328nm.
The lipid droplets are the most prominent feature of 
fat-storing cells, and contain vitamin A metabolites such 
as retinyl esters (Brouwer et al 1986), high concentrations 
of retinol binding proteins and retinoic acid binding 
protein, and cholesterol. The number of fat droplets 
varies with age and diet. Fat-storing cells contain 75% 
of the liver retinoid content, and the parenchymal cells 
contain 21% (Goodman and Blaner 1984).
The composition of the remaining cytosolic component 
is similar to that of fibroblasts, with well developed 
endoplasmic reticulum, Golgi complex, multivesicular bodies 
and some small lysosomes. Many groups have stated that 
these are in fact the precursors of the myofibroblast-like 
cells found in hepatic fibrosis (Friedman, 1990; Mak and 
Lieber, 1986).
There are few phenotypic markers for fat-storing cells 
in normal human liver. Although the presence of
cytoplasmic lipid can be used for their identification in 
semi-thin sections, these are not readily identifiable by 
routine microscopy. They can be distinguished from
Kupffer cells and endothelial cells, as they lack the 
markers for these cell types, but positive identification 
is difficult. Rat liver fat-storing cells express the
intermediate filament protein desmin and this can be used 
in immunohistochemical studies (Burt et al, 1986). Desmin 
can be demonstrated ^
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in isolated cell preparations of human fat-storing cells 
(Friedman et al, 1992) but cannot be readily demonstrated 
in immunocytochemical studies of human liver (Ahmed et al, 
1991). Activated human fat-storing cells appear to
express the a-smooth muscle isoform of actin (Matthews and 
Burt, 1993).
1.4.3 Kupffer cells
These account for about 10% of all liver cells and 80- 
90% of fixed macrophages in the mononuclear phagocyte 
system (MPS). They are anchored to the endothelial cells 
by cytoplasmic processes, with almost 50% of all Kupffer 
cells found in the periportal zone. The rest are evenly 
divided between the perivenular and midzones suggesting 
that the major site of endocytosis is where the blood 
enters the sinusoid. The contacts with endothelial cells 
do not involve structures such as desmosomes, but they are 
strong enough to prevent blood flow dislodging the Kupffer 
cells. Endocytosis can either occur as pinocytosis
(internalisation of liquids), or phagocytosis 
(internalisation of particulate matter, including bacteria 
and cell debris). As well as endocytosis, the functions of 
Kupffer cells include secretion of mediators, processing of 
antigens and their presentation to immunocompetent cells, 
and enzyme catabolism (Jones and Summerfield, 1988).
Kupffer cells have morphological appearances typical 
of macrophages. The cell body contains numerous blebs, 
microvilli and lamellipodia (Smedsrod et al, 1985), 
accounting for its stellate appearance in the sinusoid.
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Within the cytoplasm there are many lysosomes, pinocytotic 
vesicles and cisternae, indicative of the role of Kupffer 
cells in phagocytosis. Ultrastructurally this can be
demonstrated by the presence of micropinocytotic vesicles 
and both endotoxin and lysosomal enzymes may be cleared in 
this way (Stahl and Schlesinger, 1980)
If the material is particulate and greater than 
10 nm in diameter, then it is taken up by phagocytosis. 
Particulate matter can be taken up in two ways -
(i) non-specific opsonin-mediated phagocytosis, using 
substances such as fibronectin (Cardarelli et al, 1984).
(ii) immunospecific opsonin-mediated phagocytosis, 
using Fc receptors or C3 receptors (Munthe-Kaas, Kaplan and 
Seljelid, 1976).
Phagocytosis can also occur without opsonisation, e.g. as 
occurs with erythrocyte membranes (Vomel, Muller & 
Platt,1985) and tumour cells (Roos & Dingemans,1977), and 
this is due to Kupffer cells recognising cell-surface 
components on the target cells via a range of specific and 
non-specific receptors.
Kupffer cells can be activated by a range of signals 
including zymosan, endotoxin and lymphokines. Activation 
is associated with production of superoxides, uptake of 
calcium and release of lysosomal enzymes and is often 
accompanied by increased proliferation of the cells.
There is no known primary role for Kupffer cells in 
the production of extracellular matrix components, but they 
are known to produce growth factors such as TGFfl which 
stimulate the production of extracellular matrix protein
components by other cell types such as fat-storing cells.
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(Gressner and Meyer, 1991; Friedman and McGuire, 1991)
1.4.4 Sinusoidal endothelial cells
Endothelial cells separate the sinusoidal lumen from 
the hepatocytes, between which lies the space of Disse. 
They form a tenuous and selective barrier, as the cells are 
fenestrated and allow the passage of fluids and solutes 
from the sinusoidal lumen to the space of Disse (DeZanger 
and Wisse, 1982). Ultrastructurally, the cell consists of 
a cell body with a nucleus, and slender extended processes. 
It contains a large number of pores which are arranged in 
sieve plates. The size of the fenestrae is important in 
determining access to the space of Disse and the 
hepatocytes. The diameter of the fenestrae can be altered 
by hormones, drugs and alcohol, probably via the 
cytoskeletal fibrils (McGuire et al, 1992).
Sinusoidal endothelial cells also contain membrane 
invaginations and lysosomal vesicles which indicate that 
these cells are capable of endocytosis. They can take up 
substances such as immune complexes, denatured albumin, 
collagen, heparin, colloidal carbon, colloidal silver and 
transferrin (Brouwer, Wisse and Knook, 1988).
The most reliable method for identification of 
endothelial cells is by their ultrastructural features, and 
this is preferable to the use of markers such as factor 
VIII related antigen (Irving et al, 1984) and the Fc and 
mannose membrane receptors (Shaw et al, 1984). A
11
combination of these markers may be necessary for definite 
identification.
1.4.5 Pit cells.
These were first described in 1970 by Wisse and Daems, 
and are now thought to represent tissue-associated large 
granular lymphocytes (Bouwens et al, 19 87; Bouwens and 
Wisse, 1987). They are located in the lumen of the
sinusoid, and are often adherent to endothelial cells. 
They have been characterised as non-phagocytic, non­
adherent, peroxidase-negative and acid phosphatase 
positive. In humans they are also identifiable as asialo 
GM1 positive, CD56 positive CD16 negative.
The ultrastructural features are those associated with 
lymphocytes, but the cytoplasmic volume is greater than in 
most circulating lymphocytes. Characteristic organelles 
include electron-dense cytoplasmic granules and rod-cored 
vesicles (diameter of 0.2^ /m). It has been proposed that 
these cells act as natural killer (NK) cells within the 
liver, and may play an important role in defence against 
hepatitis viruses, and against hepatic neoplasia (Geerts, 
Bouwens and Wisse, 1990; Vanderkerken, Bouwens and Wisse, 
1990) .
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2.1 Liver injury
The response of the liver to injury can vary widely. 
Each response can be regarded as part of a continuous 
spectrum which ranges from transient acute inflammation to 
chronic hepatitis and cirrhosis. This chapter will
examine the possible responses to injury, as well as some 
of the more common causes of injury. Hepatocytes bear the 
brunt of most forms of liver injury and some, indeed most, 
of the tissue response involves the non-parenchymal cells
2.1.1 Sub-lethal injury
There are a number of sub-lethal injuries which can be 
found in hepatocytes. One common example is fatty liver 
or steatosis. The hepatocyte accumulates fat within its 
cytoplasm which may be present as a single droplet 
(macrovesicular steatosis) or as a number of small droplets 
(microvesicular steatosis). The fat is mainly in the form 
of triglycerides. Steatosis often accompanies obesity and 
is an early manifestation of alcoholic liver injury. There 
is rarely any functional impairment associated with simple 
steatosis per se, and there is little evidence that it
progresses to cirrhosis.
Degeneration of hepatocytes often precedes necrosis 
and can take several forms including the feathery
degeneration found in cholestasis or the appearance of the 
ballooned cell, where the cytoplasm appears empty apart
from a few wisps ;surrounding the nucleus which is enlarged
as seen in alcoholic hepatitis.
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2.1.2 Necrosis
This can be the result of many types of liver damage. 
It can involve individual cells or groups of cells within 
the hepatic acinus or may in some instances affect the 
entire liver. Different morphological patterns of
necrosis are identified as follows.
(a) Focal or spotty necrosis. This can be found in 
any zone of the acinus. It is common in viral hepatitis.
(b) Zonal necrosis. This can affect any of the three 
zones of the acinus and each pattern may indicate the 
underlying cause. Perivenular necrosis is typical of 
ischaemic injury, and may also be found in drug or 
chemotoxic reactions. Midzonal necrosis is very unusual 
and is associated with yellow fever. Periportal necrosis 
is found in cases of eclampsia and in some types of 
poisoning e.g. phosphorus.
(c) Submassive (panacinar) necrosis. This is
clinically referred to as fulminant hepatitis. There are 
a number of different causes, with some of the more common 
ones including acute viral hepatitis, drug toxicity and 
chemical toxicity.
(d) Piecemeal necrosis. This affects the cells at 
the interface between connective tissue and parenchymal 
tissue. It characteristically comprises a predominantly 
lymphocytic infiltrate, and can be found around portal 
tracts, the septa of fibrotic liver and the necrotic 
bridges of viral hepatitis. It was initially described by 
Popper et al (1965) who emphasised its immunological 
aspects.
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2.2 Response to liver injury.
The first response to almost all types of cell injury 
is inflammation. It is a necessary first step in the 
repair of damaged tissue, but it is also a potentially 
harmful process. Inflammation can result in complete
resolution of the injury, or it may lead to a number of 
other outcomes.
2.2.1 Inflammation
Inflammation can be divided into acute and chronic 
patterns.
Acute inflammation is a short lived response lasting 
from several minutes to several days which is characterised 
by (i) the change in vascular flow and size of the blood 
vessels;(ii) change in vascular permeability, and (iii) 
the margination and movement of leukocytes from the 
intravascular space to the interstitial tissues. This is 
the most important feature of the inflammatory response and 
can be divided into stages- first the leukocytes come in 
contact with the endothelial cells instead of flowing 
freely along the centre of the vessel. The leukocytes now 
adhere firmly to the endothelial surface via specific 
adhesion molecules. After adhesion, the leukocytes move 
through the gaps between the endothelial cells into the 
space between the endothelial cells and basement membrane, 
before crossing the basement into the extracellular space. 
The cells are directed by a process known as chemotaxis, in 
which the cells move along a chemical gradient. The next 
stage is phagocytosis : this is the ingestion of
particulate matter by the leukocytes. Neutrophils and
macrophages recognise "foreign" particles, then engulf the 
particles by encircling them with cytoplasmic processes and 
enclosing them within a phagosome. This fuses with a
lysosome and the contents are degraded. When lysosomal 
enzymes are released during phagocytosis, they are powerful 
mediators of inflammation, and amplify the inflammatory 
process .
Although this is a simplified description of acute 
inflammation, the basic process is similar, independent of 
the initial stimulus, and the histological pattern can be 
easily identified. The process of acute inflammation is 
seen in some forms of biliary damage when there is 
obstruction to biliary flow and accompanying infection. 
It can also be seen when there is sepsis in extrahepatic 
sites. It may completely resolve (often in mild injury) 
or heal after the process of scarring has occurred. It 
may also progress to chronic inflammation.
A more common response to injury in the liver is 
chronic inflammation which may occur de novo i.e. without 
an initial acute phase, or may follow acute inflammation. 
The causes of chronic inflammation include persistent 
infection by virus, infection by tubercle bacillus, 
prolonged exposure to foreign matter, and autoimmune 
disease. There are several histological markers of
chronic inflammation including infiltration of macrophages, 
lymphocytes and plasma cells; proliferation of fibroblasts 
and small blood vessels; an increase in connective tissue 
(fibrosis); and tissue destruction (necrosis). The
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difference between acute and chronic inflammation is not 
always clear-cut.
2.2.2 Regeneration
Cells can be divided into three groups based on their 
ability to regenerate. Hepatocytes are stable cells i.e. 
under normal conditions they have a low mitotic rate with 
constant low level turnover. After injury such as partial 
hepatectomy or viral infection, the stable cells (i.e. 
hepatocytes) are stimulated to undergo cell proliferation.
The replication of such cells does not guarantee 
restoration of normal tissue structure and function. In 
order for this to occur, there must be an intact underlying 
framework. If the connective tissue framework and
basement membrane is damaged, regeneration may be haphazard 
and result in scarring.
The factors which control hepatic regeneration have 
not yet been fully identified. Signals or mediators are
necessary to switch on rapid cell proliferation after 
injury, and also to switch off the proliferation when the 
liver is restored to its normal size. Possible mechanisms 
include functional overload, and circulating substances 
such as hormones, nutrients and growth factors.
Growth factors which have been implicated in hepatic 
regeneration include hepatocyte growth factor (HGF) and 
transforming growth factors a and B (TGFa and TGFB). In 
experimental models of liver regeneration such as partial 
hepatectomy or CC14 intoxication of rats, a rapid increase 
in serum HGF can be demonstrated within several hours.
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The levels of HGF measurable exceed the level known to be 
mitogenic for hepatocytes in culture (Michalopoulos and 
Zarnegar, 1992). Mead and Fausto (1988) have shown that 
TGFa is produced by regenerating hepatocytes and may act in 
an autocrine manner to promote hepatic regeneration. In 
contrast, TGFB acts as an inhibitor of cell proliferation.
2.2.3 Fibrosis and Cirrhosis
Fibrosis is the accumulation of extracellular matrix 
proteins as a result of alterations in the balance of 
synthesis and degradation. Fibrotic septa in the liver 
can be either active (formed by new connective tissue), or 
passive (produced by the collapse of pre-existing 
connective tissue after liver cell damage). In the early 
stages, fibrosis is reversible, if the stimulus is removed. 
The pattern of fibrosis may be focal - scarring around a 
localised injury, or may extend over large areas of the 
acini.
In some cases, fibrosis may proceed to cirrhosis. 
This is a well defined process which involves the formation 
of regenerative nodules. There are several pre-requisites 
for the histological diagnosis of cirrhosis. The
architecture of the liver must be disrupted; the scarring 
divides the parenchyma into nodules, and the hepatic 
vascular architecture is reorganised because of this and is 
associated the development of new arteriovenous 
connections.
Conventionally there are two categories of cirrhosis- 
micronodular, where the majority of the parenchymal nodules
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are less than 3mm in diameter; and macronodular, where the 
nodules are greater than 3 mm. In micronodular cirrhosis, 
the septa tend to be slender and regular in width, although 
wider septa may be seen. The pattern is to some extent 
dependent on the aetiology of the disease. Thus alcoholic 
cirrhosis is classically micronodular. Portal tracts or 
hepatic vein branches may disappear, due to portal-central 
bridging fibrosis. Macronodular cirrhosis may have wide 
or thin fibrous septa, and the nodules often contain portal 
tracts and central veins, although they may be unusually 
close to each other. Because of the larger nodules,
diagnosis can be difficult with needle biopsies. It is 
generally the case that macronodules arise from 
regenerative micronodules, although some cirrhoses are 
macronodular from an early stage.
The clinical effects of cirrhosis include portal 
hypertension, splenomegaly, ascites and hepatic 
encephalopathy.
2.2.4 Carcinogenesis
Hepatocellular carcinoma (HCC) accounts for over 90% 
of primary liver malignancies, and worldwide, between 60 
and 90% of HCCs are associated with cirrhosis. There is 
evidence linking protracted infection with hepatitis B, and 
to a lesser extent hepatitis C, with HCC. This helps to 
explain the high incidence of HCC in Africa and South-East 
Asia when compared with Europe and the United States. 
This subject is reviewed by Okuda (1992)
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2.3 Types of liver injury
There a number of possible causes of liver injury. 
The causative agent may affect both the pattern of injury 
and the eventual outcome. A number of different agents 
are described below. It should be remembered that there 
may be some overlap. This is not an exhaustive list, there 
are also metabolic forms of liver injury whereby enzyme 
deficiencies lead to accumulation of amino acids, proteins 
and sugars in the liver and this may result in liver cell 
necrosis (Ishak and Sharp, 1987).
2.3.1 Viral
There are a number of viruses which specifically 
infect humans and are associated with liver cell necrosis. 
The most common of these are hepatitis A, B and C 
(previously known as non-A,non-B hepatitis). In addition 
some viruses which infect predominantly extrahepatic 
tissues can also be associated with hepatocyte injury. 
These include Epstein-Barr virus and Cytomegalovirus. 
Hepatitis lasting less than six months is known as acute 
hepatitis, if it lasts longer, it is known as chronic 
hepatitis.
Hepatitis A "infectious hepatitis" is caused by a 27nm 
RNA enterovirus which is spread by the oral-faecal route 
and may occur in epidemics. The disease is usually mild 
and is brief in duration. The mortality rate is extremely 
low, and there are few long-term complications.
Hepatitis B "serum hepatitis" is transmitted 
parenterally and requires direct innoculation through skin
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or mucous membrane. Hepatitis B is a partially double 
stranded DNA virus which is found as a 42nm particle. The 
clinical disease is more severe than hepatitis A, and about 
10% of cases are complicated by chronic infection. These 
patients may become asymptomatic while still retaining the 
infectious virus particles (carriers), or may develop 
chronic hepatitis and ultimately cirrhosis and 
hepatocellular carcinoma.
Much of the hepatocellular damage is caused by 
associated T-cell mediated immunological mechanisms rather 
than direct viral toxicity and there is a wide variation in 
the outcome of HBV infection (Bianchi, Spichtin and Gudat, 
1987) .
Hepatitis C is a single-stranded RNA virus, 
responsible for >90% of transfusion related non-A, non-B 
hepatitis, and a substantial proportion of sporadic non-A, 
non-B hepatitis. It results in a clinically mild, or even 
asymptomatic illness but in about 50% of cases, it 
progresses to a chronic hepatitis and subsequent cirrhosis. 
There are several histological features which are typical 
of hepatitis C infection, including dense focal lymphocytic 
portal infiltrates, steatosis, Kupffer cell hyperplasia and 
abnormal bile duct epithelium (Underwood, 1990)
There are other hepatitis viruses. Hepatitis D or 
delta agent only occurs in patients who also have hepatitis 
B and superinfection in such patients is associated with 
exacerbation of liver disease. Hepatitis E is a
calicivirus. Both of these have been sequenced. Two 
other recently described but poorly characterised hepatitis
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viruses are hepatitis F, a togavirus associated with 
fulminant acute hepatitis; and hepatitis G, possibly a 
paramyxovirus involved in giant cell hepatitis.
Acute viral hepatitis has a typical picture of diffuse 
liver cell injury, liver cell necrosis, hypertrophy of 
Kupffer cells, inflammatory infiltrate in the portal tract, 
and regeneration of hepatocytes in the recovery period. 
In more severe cases, the necrotic areas may connect, 
(bridging necrosis) and this may be portal-portal, central- 
central or portal-central.
In chronic hepatitis, there are two main patterns. 
In chronic persistent hepatitis (CPH) there is minimal 
hepatocyte necrosis, and the inflammatory infiltrate is 
limited to the portal tracts. This condition however
forms part of a spectrum which also includes chronic active 
hepatitis (CAH) in variable amounts of both necrosis and 
fibrosis occur. The portal infiltrate spills out of the 
portal tract with the development of both piecemeal and 
bridging necrosis. Fibrosis which results from this
rsponse extends from the portal tracts into the parenchyma 
and may progress to cirrhosis.
2.3.2 Toxins.
There are many toxins and drugs which can produce 
hepatic injury. This is reviewed in Zimmerman and Ishak, 
1987. One of the commonest hepatotoxins is alcohol, which 
has been linked with liver damage for centuries. Alcohol 
(ethanol) is metabolised within the hepatocytes, and the 
resultant intermediate metabolite , acetaldehyde, is toxic
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to liver cells. The resultant alteration of the redox 
potential of these cells leads to altered lipid metabolism 
and the accumulation of cytoplasmic triglycerides. This 
explains one of the early sublethal forms of alcohol- 
induced liver injury. Steatosis, often an early feature 
of alcoholic liver disease, is reversible if alcohol is 
withdrawn but may be associated with the formation of 
lipogranulomas. If alcohol intake continues, there may be 
progress to alcoholic hepatitis although this is influenced 
by factors involving individual susceptibility. Most of 
the changes of alcoholic hepatitis are found in the 
perivenular zones, and there is a distinctive histological 
pattern. The hepatocytes are swollen, with Mallory bodies 
(alcoholic hyalin) present, and there is a neutrophil 
polymorph infiltrate present. Fine pericellular fibrosis 
is also a common finding, as well as early septum 
formation. Steatosis is still present in many cases.
This in turn may progress to alcoholic cirrhosis, when 
there is widespread disruption of normal liver 
architecture. Nodules are surrounded by the connective 
tissue septa, and regeneration occurs within these nodules. 
The septa are formed by active fibrogenesis, rather than by 
the collapse of pre-existing structures. The first areas 
of fibrosis are around the hepatic veins, with eventual 
spread to the portal areas, resulting in portal-portal or 
portal-central bridging.
There are a number of ultrastructural changes which 
are typical of alcohol-induced injury. Mitochondria are 
swollen and enlarged, with the number of cristae reduced,
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leading in some cases to the formation of so-called giant 
mitochondria. The endoplasmic reticulum becomes swollen 
and disrupted, with the formation of vesicles.
There are many other drugs which are hepatotoxic, and 
these involve one of the following mechanisms -
a) The drug, or one of its metabolites, may be directly 
hepatotoxic e.g. paracetamol or carbon tetrachloride, and 
have a physicochemical affect on the hepatocyte or on its 
organelles.
b) The drug is indirectly hepatotoxic and interferes with a 
metabolic pathway. The structural lesion is secondary and 
there are a number of different lesions which can occur. 
(Zimmerman and Ishak, 1987)
2.3.3 Cholestasis
The term cholestasis means a disturbance of the normal 
bile secretory mechanisms. It can be diagnosed by the 
accumulation of bile pigment within the liver tissue, and 
this can be done at an early stage using electron 
microscopy. The bile constituents can also be found in 
the blood. The cholestasis can be termed intra- or extra- 
hepatic, depending on where the causal lesions are found.
Extra-hepatic cholestasis indicates blockage of large 
bile ducts outside the liver, or within the porta hepatis. 
Causes include gallstones, tumours and benign strictures. 
The early microscopic changes consist of fine intracellular 
bilirubin granules, and bile thrombi with portal oedema and 
inflammation. The bile ducts start to dilate, and this is 
followed by ductular proliferation. In the later stages,
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these changes become more pronounced and feathery 
degeneration of hepatocytes affects groups of cells before 
they are lysed (cholate stasis). Subsequent ductular
proliferation is apparent, often associated with 
progressive portal fibrosis towards, and affecting linkages 
between portal tracts. One possible complication is that 
of secondary biliary cirrhosis. The inflammatory reaction 
leads to scarring and subsequently to cirrhosis.
The second type of cholestasis is intra-hepatic
cholestasis. This can be further divided into diseases in 
which the abnormality is in the hepatocytes or canaliculi ; 
and those where the damage is in the intrahepatic bile
ducts. The causes of the former include viral hepatitis, 
drug-induced cholestasis, alcoholic hepatitis, cholestasis 
of pregnancy and c^-antitrypsin deficiency. So-called
extralobular cholestasis is found in primary biliary 
cirrhosis and primary sclerosing cholangitis.
2.3.4 Autoimmune disease
There are a number of liver diseases which are
believed to have an underlying auto-immune cause. Two 
disorders classically regarded as auto-immune diseases are 
primary biliary cirrhosis (PBC) and the so-called lupoid 
chronic active hepatitis. Primary biliary cirrhosis is 
usually found in middle-aged women, and may be accompanied 
by other auto-immune diseases such as scleroderma, Sjogrens 
syndrome and the sicca syndrome. The initial lesion is 
autoimmune damage to the bile ducts, with cirrhosis
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developing later on. It is divided into 4 stages by
histological diagnosis (Portmann and MacSween, 1987).
Stage 1. Inflammation of portal tracts and damage to 
medium-sized ducts.
Stage 2. Reduction in the number of medium-sized ducts, 
and proliferation of small bile ducts.
Piecemeal necrosis in the periportal region.
Stage 3. Inflammation starts to resolve, but fibrotic
septa formation begins. Bile ducts are reduced 
or absent.
Stage 4. Cirrhosis is now found, along with regenerative 
hyperplastic nodule formation.
Chronic active hepatitis is also believed to have an 
auto-immune basis, and may overlap with PBC in some 
patients.
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3.1 Components of the extracellular matrix.
The extracellular matrix contains 4 distinct groups of 
macromolecules, and these groups are present in all 
extracellular matrices, although the amount and composition 
varies depending on site. The four groups are (i) 
Collagens, (ii) Structural glycoproteins, (iii) 
Proteoglycans / glycosaminoglycans and (iv) Elastin. 
These have been reviewed by a number of authors including 
Miller and Gay (1987) and Labat-Robert et al (1990)
3.1.1 Collagens
At present, 14 different types of collagen have been 
isolated and at least partially characterised (Labat- 
Robert, Bihari-Varga and Robert, 1990), and the genes for 
several have been fully sequenced. The property common to 
all the collagens is the presence of the classical triple 
helix within the molecule, although the extent of the 
helical formation varies between the collagen types. The 
triple helix is formed from the repetitive sequence (Gly- 
Xaa-Yaa)n, with many of the X positions filled by proline, 
and the Y positions by hydroxyproline. Each collagen is 
believed to be a product of a different gene.
Little is known of the function of the most recently 
identified collagens, as these were discovered by probing 
genomic libraries for the repeating sequences which are 
typical of the collagen triple helix. The commoner
collagens act as the "scaffolding" of the matrix. This 
can be in the form of collagen fibres which are relatively
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rigid structures (i.e. types I, II and III) , or forming 
the mesh-like framework of the basement membrane (type IV)
3.1.2 Glycoproteins
These extracellular matrix components play a major 
role in cell-matrix interactions. Members of the family 
include fibronectin, vitronectin, laminin, undulin, nidogen 
and thrombospondin. One of the best characterised in
terms of structure and function is fibronectin, which has 
been fully sequenced, and which has many isomers; these are 
derived from differential splicing of fibronectin mRNA.
The cell-matrix interactions are often mediated by a 
specific amino acid sequence called the RGD or Arg-Gly-Asp 
sequence, which can interact with integrins (Ruoslahti and 
Pierschbacher, 1988). This sequence has been identified
in fibronectin, vitronectin, laminin, thrombospondin, 
tenascin and nidogen. Integrins are a family of cell- 
membrane receptors which interact with cytoskeletal
components such as actin, talin and vinculin; this
system can therefore transmit signals from the 
extracellular matrix proteins to the interior of the cell. 
In such a complex system it seemed unlikely that the RGD 
sequence was the only recognition sequence, and laminin has 
already been shown to contain another recognition sequence 
Tyr-Ile-Gly-Ser-Arg (Martin, 1987)
As well as these cell-recognition sequences,
glycoproteins can recognise other binding sites. In the 
case of fibronectin, there are binding sites present for
collagen, heparin, hyaluronic acid, actin and the plasma
30
membrane (Hynes, 1985). Laminin has similar sites for 
collagen type IV, heparan sulphate, entactin, endothelial 
and epithelial cell membrane receptors (Aumailley et al, 
1987). This indicates that the glycoprotein molecules are 
not only involved in cell-matrix interactions, but also in 
matrix-matrix interactions,
3.1.3 Proteoglycans
Proteoglycans (originally called acid
mucopolysaccharides) consist of a protein backbone with 
glycosaminoglycan chains covalently attached. The only 
exception is hyaluronic acid which has no protein backbone. 
The glycosaminoglycans consist of repeating disaccharide 
units (an amino sugar and a uronic acid molecule). The most 
abundant proteoglycans are heparan sulphate, dermatan 
sulphate, chondroitin sulphate, keratan sulphate and 
heparin (Ruoslahti, 1988). They can be found in loose 
connective tissue and basement membranes, with the basement 
membrane proteoglycan most likely to be heparan sulphate 
proteoglycans. They occupy a large volume in relation to 
their mass as they are too inflexible to form compact 
globular structures. Instead, they form extended random- 
coiled structures which are highly hydrophilic, and which 
form hydrated gels. It is these gels which resist
compressive forces within the extracellular matrix, in 
contrast to collagen which resists stretching forces.
3.1.4 Elastin
Elastic fibres consist of elastin surrounded by an 
amorphous glycoprotein matrix. The matrix consists of a
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number of microfibrils including fibrillin (Sakai, Keene 
and Engvall, 1986), but the total number and proportion of 
different glycoproteins present has not been determined. 
There are at least 11 mRNA isomers for elastin formed by 
splicing of the gene (Parks and Deak, 1990). Elastin is 
synthesised as the soluble precursor tropoelastin, which is 
then cross-linked to form the mature elastin fibres. 
Mature elastin has rubber-like properties, but during aging 
the fibres are attacked by proteases and gradually lose 
their elasticity.
3.2 Structure of the extracellular matrix
Assembly of the extracellular matrix is a complex
process, both for individual components and for the final
matrix. The chemical sequence of each of the matrix
components dictates the structure of that component, and 
the components used for each tissue-specific matrix 
determine the final characteristics of the matrix. The
matrix is normally assembled immediately at the cell
surface, but this depends on the tissue and cell type 
involved.
Due to the sequential assembly, it is likely that the 
first components to be laid down act as templates for later 
matrix assembly. One such early component is fibronectin. 
In wound healing and embryological development, fibronectin 
matrices act as a cell adhesion and guidance system (Vartio 
et al, 1987; Sternberger and Kimber, 1986).
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3.3 Roles of the extracellular matrix.
For many years, the extracellular matrix was regarded 
as an inert scaffolding which was only used as a physical 
support for the tissue. As the complex nature of the 
extracellular matrix protein components has been 
discovered, many new functions have been proposed for the 
extracellular matrix. Extracellular matrix proteins are 
now known to be involved in the regulation of cell 
migration, development, shape, metabolism and growth (Buck, 
1987) .
The role of the extracellular matrix in determining 
the phenotype of cells has been shown in tissue culture, 
where the choice of culture substrate has a major effect on 
the cell phenotype (Bucher , Robinson and Farmer, 1990).
Most cells interact in vitro with collagens and 
glycoproteins. This can be demonstrated by coating
culture dishes with purified matrix proteins and plating 
cells on the surface. This may involve individual
components such as type I collagen, or the use of a complex 
mixture such as that obtained from the Engelbreth-Holm- 
Swarm sarcoma (EHS) (Schuetz et al, 1988). EHS contains a 
mixture of basement membrane components such as laminin, 
type IV collagen and heparan sulphate proteoglycan, as well 
as growth factors such as TGFB.
Most studies of gene expression by liver cells have 
been carried out using hepatocyte cultures under different 
culture conditions (Bucher, Robinson and Farmer, 1990). 
Hepatocytes grown under classical tissue culture conditions 
(i.e. on plastic tissue culture dishes) only survive for a
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few days, and rapidly lose all tissue specific gene 
expression. In comparison, common genes such as those for 
actin and tubulin are transcribed at normal levels. The 
use of type I collagen rafts as a substrate led to 
prolongation of viability and of tissue-specific gene 
expression (Michaelopolis and Pitot, 1975). As the
cultures age, the gene expression gradually changes to an 
embryonic pattern. It has been suggested that this
pattern resembles that found in human cirrhosis (Reid, 
Abreu and Montgomery, 1988). Other substrates tested
include type III collagen (poor growth, gene expression 
similar to guiescent liver (Narita et al,1985); type IV 
collagen (grow rapidly with gene expression similar to 
regenerating liver); and the adhesion proteins,
fibronectin and laminin (which improve cell adhesion and 
life span of cultures but do not prolong liver-specific 
gene expression, Bissell et al, 1987).
More recently several groups have used complex native 
substrates for hepatocytes. Using EHS gel as a substrate, 
the life of the cultured cells was increased, and they 
maintained a rounded shape throughout culture, unlike those 
grown on collagen. When gene expression was examined, the 
transcription of liver specific genes was maintained at a 
level similar to that of normal liver (Bucher et al, 1990). 
The difference was that the total DNA synthesis was greatly 
inhibited, and this may be due to the presence of TGFB 
within the EHS matrix.
These studies have helped to explain one of the 
functional roles of the extracellular matrix. If the
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ability of the hepatocyte to produce liver-specific 
proteins is affected by the substrate to which it is 
attached , alterations in the pattern of extracellular 
matrix protein synthesis and composition of the matrix will 
lead to changes in liver function.
If the pattern of extracellular matrix protein 
deposition affects both structural and functional aspects 
of the liver, then localisation of the different types of 
matrix proteins may explain some of the alterations in cell 
function during fibrosis.
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4.1 Collagen
The term collagen encompasses a large family of 
glycoproteins. Collagen forms the most abundant group of 
proteins in mammals, and is often found in the form of 
insoluble fibres. The role of collagen fibres is primarily 
structural, but depending on their location the fibres may 
be rigid or flexible. The location within the tissue also 
determines the type of collagen found. This chapter will 
describe the different types of collagen and their 
classification, with particular reference to those which 
may be present in liver.
4.2 The chemical structure of collagen.
All collagen molecules consist of three polypeptide 
chains, or a-chains. The repeated sequence (Gly-Xaa-Yaa)n 
is present in the helical regions of the chains. The 
glycine residues are compact, and lack side-chains, and 
this allows the formation of the tight triple-helical 
structure which is characteristic of collagen. The X 
position is filled by proline, leucine, phenylalanine, 
glutamic acid or aspartic acid, and the Y position by 
proline, 4-hydroxyproline, glutamine, arginine or 
threonine. The imino acids are randomly distributed
between X and Y positions, but have increased 
concentrations at the -NH2 and -COOH regions. This may 
help prevent the unravelling of the helix in these regions 
(Miller and Gay, 1988; Kivirikko and Mylylla, 1984). The 
collagen chains are synthesised within the cell, to form 
the helical procollagen molecules, and then undergo
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intracellular processing. In the endoplasmic reticulum, 
some of the residues are hydroxylated by prolyl hydroxylase 
or lysyl hydroxylase. This is essential for further 
collagen processing and requires 02, ferrous iron, a- 
ketoglutarate and ascorbic acid. The subsequent oxidative 
deamination of these sugars to active aldehydes helps to 
bond the three a-chains into a tight helix (Kivirikko and 
Myllyla, 1984).
Five specific enzymes are required: prolyl-3-
hydroxylase, prolyl-4-hydroxylase, lysyl-hydroxylase, 
galactosyl transferase and glucosyl transferase. There is 
also some degree of glycosylation of asparagine residues at 
the -COOH terminal via the dolychol pathway. This occurs 
while the collagen is in the Golgi apparatus.
Procollagen is processed through the rough endoplasmic 
reticulum and Golgi apparatus and exported to the 
extracellular space, via secretory vesicles. Once
secreted, these procollagen molecules have their C and N 
extension peptides removed by procollagen peptidases. 
This occurs to a variable extent - some such as type III 
collagen may retain the propeptide molecules. The
tropocollagen molecules formed by this process are also 
called collagen filaments. They have a diameter of 1.5nm 
and are approximately 300nm long. The tropocollagen then 
aggregates to form collagen fibrils. Finally, the fibrils 
aggregate together to form collagen fibres with diameters 
°f 1-10 jL/m (Ghadially, 1990).
Covalent bonding between the filaments is followed by 
irreducible cross-links between fibrils. As collagen
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COLLAGEN TYPE NORMAL CIRRHOSIS
I 40 - 50 60 - 70
III 40 - 50 20 - 30
IV 1 1 - 2
V 2 - 5 5 - 10
VI 0.1 1
Table 4.1 Approximate percentage of principal collagen types 
in normal and cirrhotic human liver, (after Schuppan, 1990)
matures, it becomes progressively less soluble, and the 
mature fibres have high tensile strength. These mature 
fibres are deposited in tissue as loosely associated 
bundles. In all collagens, coiling of the three a-chains 
( which may be discontinuous in places) takes place within 
the cell, then the molecule is secreted to form 
tropocollagen fibrils. After extracellular processing, a 
number of these tropocollagen fibrils associate laterally 
and form collagen fibres. The collagen a-chain can be 
divided into three main regions
i) the amino terminal peptide ( pN )
ii) the carboxy terminal peptide ( pC )
iii) the triple helix
4.3 Classification of collagens
Until 1969, it was thought that there was only one 
type of collagen. The criterion for designation as a 
collagen molecule is the presence of a sizeable domain in 
which the triple helical structure is present By 1990, 
fourteen different proteins with this characteristic 
feature had been described (Labat-Robert, Bihari-Varga and 
Robert, 1990). The current classification of collagens is 
based on physico-chemical properties, and gives three 
separate groups of molecules.
4.4 Group 1 collagens
Collagens in this group have chains of at least 95,000 
Da, and contain uninterrupted triple-helical regions of at 
least 300nm; they are also referred to as the interstitial
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Collagen Chains
Chain M 
Procollagen
weight
Collagen
Molecular
species
Type I al(I) 140,000 95,000 al (I)2a2(I)
a2 (I) 125,000 95,000 al(I)3
Type II al(II) 140,000 95,000 al(II)3
Type III al(III) 140,000 95-110,00 al(III)3
Type V a 1(V) 240,000 115,000 al(V)2a2(V)
a2 (V) 160,000 ? al(V)3
of 3 (V) ? ? al(V)a2(V)a3(V)
TABLE 4.2 Group 1 collagen molecules
collagens. Collagens in this group display a
characteristic banding pattern with a 67 nm periodicity on
electron microscopy. This is due to the collagen
molecules associating laterally, but with a relative
stagger of 67 nm. This arrangement alternates gap and 
overlap zones within the fibre. At the present time, there 
are five collagens in group 1 (Table 4.2). Of these, types
II and XI are only found in cartilage and will not be
discussed here.
It has recently been suggested that most, if not all 
banded fibres consist of more than one type of collagen
(Burgeson 1988). This has been demonstrated in several 
tissues - banded fibres in chick cornea are co-polymers of 
types I and V (Adachi and Hayashi, 1986; Birk et al, 1988)
; skin fibrils and aorta contain types I and III and 
possibly type V (Fleischmajer et al, 1985) ; tendon fibrils 
contain types I and III (and possibly type XI). The
different types of collagen play an important role in 
regulation of collagen fibre size, and the types of 
collagen present are determined by the type of tissue. The 
ratio of collagen types present may control indices such as 
fibril diameter and fibril orientation. In vitro studies 
of fibrils formed from mixtures of type I and type III 
collagen show an inverse correlation between the proportion 
of type III present and the fibril size (Lapiere, Nusgens 
and Pierard, 1977). This may be due to the fact that type 
I procollagen tends to be completely processed, while type
III procollagen may keep a variable proportion of its 
propeptide. If the propeptides are still present on the
surface of the collagen bundle, it will not continue to 
increase in diameter (Schuppan, 1990). This is contrary to 
previous reports about the relationship between type III 
collagen and fibril diameter (Keene et al, 1987). Fibre 
diameter may also be affected by the degree of 
glycosylation (Miyahara et al, 1984).
Type I collagen.
This is the predominant collagen found in vertebrates. 
There are two different chains, and two molecular species. 
crl(I)2 a2(I) is the most common species, and al(I)3 is
found infrequently. The pro-a chains are cleaved at the N- 
terminal peptide then at the C-terminal peptide (Davidson, 
McEneany and Bornstein, 1975). After cleavage, the a-
chain consists of a large triple-helix ( 1014 amino acid
residues, 300nm ) with short non-helical ends, and the
fibres then aggregate to form thick bundles. Type I
collagen has a low percentage of hydroxylysine-linked
carbohydrate (0.5-1%), and the ultimate fibre diameter is 
inversely linked to the content of neutral hexose. 
Physically, it can be regarded as a semi-flexible rod and 
this flexibility may be required during fibrillogenesis.
Type I collagen can be identified in almost all 
interstitial connective tissues (including skin, bone,
cornea and liver).
Type III collagen.
There is only one chain type and the molecular species 
is a trimer of al(III), often found in association with 
type I collagen. Extracellular processing is not always
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complete, and chains retaining the N-terminal peptide are 
often present in tissue. It is believed that these
terminal peptides must be removed from the fibril surface 
before the fibrils can grow. High levels of the cleaved 
terminal pIIIP can often be measured in serum, and this may­
be clinically useful for measurement of type III collagen 
turnover although there is some debate about this (Mutimer 
et al, 1989 ) .
Type III collagen is also found in interstitial
connective tissues, but is unusual in fully calcified
tissues such as bone. In distensible structures such as 
arteries it is relatively abundant in comparison to type I 
collagen
Type V collagen.
Three different chains and three molecular species
have been described - al(V)3 ; al(V)2 «2(V) ; al(V) a2(V)
a3(V) (Miller and Gay, 1987; Fessler and Fessler, 1987). 
In earlier literature it is referred to as AB collagen.
The procollagen form is similar to that of types I and III, 
with a 300nm triple helix and globular domains at either 
end. The larger mass of type V collagen is due to an extra 
sequence at the N-terminal (Burgeson, 1988). Extracellular 
processing is slow and not fully understood, but it is 
believed that type V retains part of the N-terminal 
sequence after processing. All of the C-terminal is 
removed at this stage.
Once it is processed, type V collagen forms fine 
fibrils by end-to-end interactions. These have a periodic
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banding pattern similar to that of types I and III (Adachi 
and Hayashi, 1985; Adachi, Hayashi and Hashimoto, 1989). 
The fibres are often located in a pericellular distribution 
and are thought to connect basement membranes with the 
interstitial collagens. They have a high specific binding 
affinity to heparan sulphate which may be involved in the 
binding to basement membranes (LeBaron et al, 1989).
This is a minor component of most tissues, where it is 
found in the pericellular interstitium, and in close 
proximity to basement membranes. Because of this, it was 
originally classified as a basement membrane component 
(Burgeson et al, 1976). It can be co-localised with other 
interstitial collagen fibres, and it has been suggested 
that fine type V fibres act as core fibrils to initiate 
growth of large fibres
There is a large increase in both absolute and 
relative amounts of this collagen in granulation tissue, 
healing wounds (Kurita et al,1985) and atherosclerotic 
vessels (Morton and Barnes, 1982).
4.5 Group 2 collagens
Collagens in group 2 also have chains with a molecular 
weight of greater than 95,000 Da, but the triple-helical 
domain is interspersed with non-helical domains. There 
are five collagens in group 2 (Table 4.3); in contrast to 
groups 1 and 3, none of these appear to be present in 
cartilage. They have end-to-end associations rather than 
lateral ones, and therefore do not form the striated 
fibres characteristic of group 1 collagens. Although the
43
I
Collagen Chains
Chain M weight 
Procollagen Collagen
Molecular
Species
Type IV al(IV) 185,000 185,000 al(IV)2a2(IV)
a2(IV) 170,000 170,000 al(IV)3
a2(IV)3
Type VI al(VI) 240,000 140,000 al(VI)a2(VI)a3(VI)
a2(VI) 240,000 140,000 al(VI)3
a3(VI) 240,000 140,000
Type VII al(VII) ? >170,000 al(VII)3
Type VIII ? 180,000 180,000 ?
Table 4.3 Group 2 collagen molecules
helical regions are interrupted, the molecules still have 
pN and pC termini.
Type IV collagen.
Two different chains have been isolated, al(IV) and 
a2(IV), giving rise to three molecular species - al(IV)3; 
a2(IV)3; al(IV)2 a2(IV)i. Type IV collagen is a key
component of basement membrane in all tissues. The
proportions of al(IV) and a2(IV) may vary in different
basement membranes (Miller and Gay, 1988). Type IV 
collagen forms a highly flexible, thread-like molecule with 
a globular region towards the carboxy terminal (NCI 
domain) , and a compact helical zone towards the amino 
terminal (7S domain). The three chains run co-linearly 
throughout the length of the molecule. Dimers are formed 
by the NCI domains binding together, and when the 7S
domains of these dimers bind they form multimers. 
Although most association is end-to-end, some lateral 
association may also occur. Within the triple helix there 
are short breaks in the structure, where glycine residues 
are missing. This allows hyper-flexibility, but also gives 
an increased sensitivity to pepsin,and thus increases the
likelihood of collagen degradation by non-specific
proteases. When the sequence of type IV collagen is
examined,there is a very low degree of homology with the 
interstitial collagens such as collagen type I and type 
III.
The collagenous component of basement membranes in all 
tissues is believed to consist exclusively of type IV
collagen. The monomers of type IV collagen link to form a 
loose meshwork, which acts as the structural frame for the 
basement membrane.
Type VI collagen.
Type VI collagen has three chains and one molecular 
species, the heterotrimer al(VI), a2(VI), a3(VI). No
obvious proteolytic processing is carried out, and the
molecular weights of the chains are al= 150,000 , a 2 =
140,000 , a3=240,000 (Colombatti et al, 1987; Bonaldo et
al,1989). The different chain lengths mean that there 
is incomplete matching within the monomer - one of
several unusual features of type VI collagen (Chu et al, 
1988) . The monomer is a triple helix of 105nm, with a 
globular domain at each terminus. There are two
short interruptions within the helix, which confer
flexibility. The globular domains are of approximately 
equal size, and make up 2/3 of the entire molecule (Timpl 
and Engel, 1987).
The monomers are assembled into dimers by an anti­
parallel staggered alignment of the helical domains, and
tetramers then form from laterally aligned dimers crossed 
in a scissor-like fashion with the non-staggered portion of 
the helical rod. The tetramers are formed within the
cell, and the outer globular domains interact
extracellularly to form long fibrillar structures (Von der 
Mark et al, 1984; Engvall, Hessle and Klier, 1986).
The structure of this collagen allows the formation of 
microfilaments, 3nm in diameter. These microfilaments
45
I
have an axial periodicity of approximately 100-120nm, with 
the periodicity arising from the placement of two 
alternating zones. One is composed of the thread-like 
portions of individual molecules, while the other consists 
of closely packed globular domains. This has lead to the 
description of type VI collagen as a "beaded filament" 
(Keene, Engvall and Glanville, 1988).
The turnover of type VI collagen appears to be high, 
as measured by levels of type VI antigen in serum , but it 
is a minor component in most tissues (Schuppan, Hahn and 
Riecken, 1988). There is little homology with other fibre- 
forming or basement membrane collagens, and type VI 
collagen has many unique features, some of which have been 
described above. To date it is the only collagen found in 
both cartilage and non-cartilagenous tissue, and it has the 
smallest triple-helical domain of any collagen. It also 
has 11 Arg-Gly-Asp sequences which indicate an involvement 
in cell attachment (Chu et al, 1988).
Although present in relatively low concentration, it 
is a ubiquitous component of the interstitial extracellular 
matrix, and has been described in a range of tissues 
including bone and dentine (Becker et al,1986), lung 
(Amenta, Gill and Marinez-Hernandez, 1988), brain vessels
(Roggendorf, Opitz and Schuppan, 1988), neural connective 
tissue (Peltonen, Jaakola, Hsiao, Timpl, Chu and Uitto 
1990), kidney, skin, muscle and liver (Von Der Mark et al, 
1984 ). It has been proposed that it functions as a
flexible network involved in the organisation of the 
connective tissue (Keene, Engvall and Glanville, 1988).
46
Type VII collagen
This is the largest collagen described to date. There 
is only one chain type, and the molecular species is 
the homotrimer of al(VII). The molecular weight is 1050 
KDa, with the triple helix accounting for 150 KDa. The 
helix is 424nm with at least one sizeable discontinuity. 
The molecule appears as a long triple helix with a 
globular domain at one end, and three smaller structures 
radiating from the globule. Dimer formation is by anti­
parallel overlap of the amino-terminals, followed by the 
excision of the NC2 domain. This then forms unstaggered 
lateral aggregates by interacting with other molecules, 
rather than by lateral growth. Type VII collagen is the 
sole or major component of anchoring fibrils between 
basement membranes and the underlying connective 
tissue matrix (Miller and Gay, 1987). Sakai et al (1986) 
did not detect any type VII collagen within the liver, and 
this correlates with the absence ultrastructurally of 
anchoring fibres. In tissues which did contain the
protein e.g. skin, chorioamnion, eye and cervix, type VII 
was found within the basement membrane zone of some 
epithelial cell layers (Leigh et al, 1988).
Type VIII collagen
There are three unique chains present in type VIII 
collagen ( previously called EC [endothelial collagen]). 
The chains have molecular weights of 180,000, 125,000 and
100,000 Da. The overall structure is one of three
triple-helical domains separated by two non-helical
regions (Miller and Gay, 1987). It is a minor component 
of most mesenchymal tissues and may be closely associated 
with the cell surface (Sage and Bornstein,1987).
Type XII collagen
This was first described by Gordon et al in 1987, when 
they screened a cDNA library from tendon fibroblasts. The 
predicted amino acid seguence is homologous, but not 
identical to, the cartilage collagen type IX. The collagen 
has now been isolated from chick tendon. The homology with 
type IX collagen suggests that type XII may associate with 
the surface of banded fibrils.
4.6 Group 3 collagens
These are the collagens with chains of less than
95,000 Da. To date, two members of this group have been 
described - type IX and type X (Table 4.4). Both are 
cartilage-specific collagens and not relevant to this 
study.
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Collagen Chains
Chain M weight 
Procollagen Collagen
Molecular
species
Type IX al(IX) 80,000 70,000
a2(IX) 80,000 70,000
a3(IX) 80,000 70,000
al(IX)a2(IX)a3(IX)
Type X al (X) 59,000 49,000 al(X)3
Table 4.4 Group 3 collagen molecules
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5.1 Fibronectin
Fibronectin was discovered in the early 1970's and was 
originally called cold insoluble globulin (Mossesson and 
Umfleet, 1970). It is a dimer consisting of two similar 
but non-identical chains, and has a molecular weight of
440,000 daltons. The two chains are joined by a
disulphide bond at the C-terminal end (Hynes, 1985). It 
not only forms part of the extracellular matrix, but is 
found in many body fluids and on the surface of many cells. 
It is unique among matrix proteins in that it exists in two 
different forms: plasma and cellular fibronectin. The
majority of the plasma form is produced by hepatocytes 
(Tamkun and Hynes, 1983) and the cellular form by 
fibroblasts (Hahn et al, 1980). A total of twenty
different isoforms are found and these are produced by 
differential splicing of mRNA (Hynes, 1985). Plasma
fibronectin contains three types of homologous repeat
sequences (I, II and III), while cellular fibronectin lacks 
one of the type III repeats called the EIIIA domain.
Fibronectin contains functional regions which bind to 
other components of the extracellular matrix, such as
heparan and collagen (MacDonald, 1988), but there is no
self assembly mechanism in solution, unlike the collagen 
components of the extracellular matrix. Fibronectin can
also act as a mediator of cell adhesion to collagens, 
fibrin and heparan via specific domains (Hynes, 1985). 
Plasma fibronectin acts as a non-specific opsonin which 
coats circulating debris and helps uptake by mononuclear 
phagocyte system (Cardarelli et al, 1984). Fibronectin is
a powerful chemo-attractant and can act as a growth factor 
for mesenchymal cells.
5.2 Vitronectin
Vitronectin is an adhesion protein with a molecular 
weight of 70,000 daltons. It is from the same family of 
adhesion proteins as fibronectin i.e it contains an RGD 
binding site, but it is biochemically different. It is 
synthesised as a single chain polypeptide but may form a 
dimer in the circulation (Preissner, 1991). It is present 
in plasma, amniotic fluid and urine as well as on cell 
surfaces (Preissner et al, 1985). Plasma vitronectin is 
mainly synthesised by hepatocytes but also by platelets, 
megakaryocytes and macrophages (Preissner, 1991). Several 
studies have shown that vitronectin is distributed at 
locations distant to the site of synthesis (Hayman et al,
1983) . When vitronectin was sequenced it was found to 
contain the RGD sequence and a number of binding sites 
including heparan, collagen and complement components 
(Cardin and Weintraub, 1989; Preissner, 1991 and Preissner 
et al, 1985) .
Vitronectin has a number of important biological 
functions including cellular adhesion (Underwood and 
Bennett, 1989), immune defence against bacteria (Fillipsen 
et al. 1990), and the regulation of coagulation, 
fibrinolysis and plasminogen activation (Preissner, 1991).
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5.3 Laminin
This is the major non-collagenous structural 
glycoprotein of basement membranes, and is a cross-shaped 
molecule formed from three chains. There are three short 
arms of the cross (37nm) with a globule-rod-globule-rod 
structure. The fourth arm (77nm) is a long rod ending in 
a large globular domain. Laminin is a large molecule with 
a molecular weight of 900,000 daltons, the three chains 
being A (440,000 Da), B1 (220,000 Da) and B2 (210,000 Da). 
The three short arms of the cross are formed from the N- 
terminal segments of the three chains. The chains then 
align in parallel to form the rod portion of the long arm. 
It is the C-terminal of the A chain which forms the globule 
of the long arm.
Laminin is a multifunctional molecule present in all 
basement membranes. It has binding sites for type IV
collagen, heparan sulphate, entactin/nidogen and cell 
membrane receptors on endothelial and epithelial cells. 
It is the pentapeptide sequence in the B1 chain (Tyr-Ile- 
Gly-Ser-Arg or Y-I-G-S-R) which is responsible for cell 
binding. Laminin has a role in anchoring cells to the 
basement membrane. The molecule can be broken down
proteolytically into a number of fragments, each with 
different properties. These include fragments 120kD and 
60kD, E8 (general cell binding), PI (cell binding,
including hepatocytes and tumour cells) and E3 (heparin
binding). Laminin acts on epithelial cells and regulates 
growth, morphology and differentiation (Martin, 1987).
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Laminin is one of the first extracellular matrix 
proteins to be produced during embryogenesis and interacts 
with many other cells and components of the extracellular 
matrix, indicating a major structural and functional role 
for laminin.
5.4 Tenascin
Tenascin was first distinguished from fibronectin in 
1984 by Erickson and Iglesias. It is a six armed
oligomer, which they called a hexabranchion, and which has 
also been called myotendinous antigen, cytotactin, J1 
glycoproteins and GMEM (Chiquet-Ehrismann, 1990). Part of 
the tenascin molecule consists of type III fibronectin 
repeats and there are also sequences homologous to 
fibrinogen and EGF. It is a very large molecule with a 
molecular weight of over 1000 kDa and unlike fibronectin is
Tenascin is secreted by fibroblasts and glial cells in
extracellular matrix molecule known to bind to tenascin is 
chondroitin sulphate although there are conflicting reports 
on binding to fibronectin (Lightner et al, 1988; Chiquet-
binding of cells to tenascin differs from that with laminin 
or fibronectin in that the cells do not flatten and spread 
on a tenascin substrate as they do on fibronectin (Chiquet-
not in a circulating form but is found only in
tissues.
tissue culture (Erickson and Bourdon, 1991). The only
Ehrismann et al, 1988) It has been shown that the
Ehrismann, 1990). The cell attachment to tenascin is
weaker and not all cells can adhere to tenascin. RGD
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sequences in tenascin were identified by Bourdon and 
Ruoslahti (1989); non-RGD receptor sequences may also be 
present but have not yet been characterised.
Tenascin is a major extracellular matrix protein in 
many developing organs (Chiquet-Ehrismann et al,1986; 
Mackie et al,1987; Vaughan et al,1987), is transiently 
present during wound healing (Mackie et al, 1988) and has 
been described in malignant tumours (Chiquet-Ehrismann et 
al,1986, Ichida et al, 1991). Strong tissue expression of 
tenascin is usually associated with growth and 
differentiation i.e tumour development.
5.5 Undulin
Undulin is a large glycoprotein composed of three 
different chains which are products of differential 
splicing of one gene (Schuppan, 1990). These chains are 
175, 180 and 270 kD. Ultrastructurally, it can be
visualised as a dumbell shaped monomer, or as an 
interconnected polymer. Using immunolabelling, the fibres 
are seen as a parallel display within dense connective 
tissues. It appears to be produced by mesenchymal cells, 
and plays a role in the organisation of collagen fibrils. 
It is usually associated with collagen types I and 
III.(Schuppan, 1990)
5.6 Thrombospondin
Thrombospondin is another large glycoprotein (450kD) 
made up of three chains with identical molecular weight 
(Lawler, 1986). The chains also have identical N-terminal
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sequences and enzyme cleavage sites. It is a multi­
functional protein and is known to interact with heparin, 
fibrinogen, fibronectin, plasminogen and type V collagen. 
It is produced by platelets, megakaryocytes, endothelial 
cells, smooth muscle cells, fibroblasts, monocytes and 
macrophages. Thrombospondin has been localised in
kidney, skin and lung and it has a similar distribution to 
the basement membrane in these tissues (Lawler, 1986)
5.7 Proteoglycans
Individual glycosaminoglycans bind to a protein 
backbone via carbohydrate linkages to form proteoglycans. 
The only exception to this is hyaluronic acid, which does 
not bind to a protein backbone. It is now believed that 
the protein backbone (or core protein) may play an 
important role in a number of functions (Gressner and 
Bachem, 1990).
The intact proteoglycans of the extracellular matrix 
are involved in matrix assembly, where the proteoglycans 
may help assemble the matrix by linking together other 
components of the matrix, and may also be involved in 
regulation of the collagen fibril thickness (Vogel et al,
1984) .
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6.1. The hepatic extracellular matrix proteins in light
microscopic studies.
There have been a large number of studies within the 
last fifteen years which examined the distribution of the 
hepatic extracellular matrix (reviewed by Schuppan, 1988, 
1990, Rauterberg et al, 1981). Unfortunately, many of 
these studies concentrated on one or two components of the 
extracellular matrix proteins, or examined a narrow range 
of diseases. The earlier studies concentrated on the 
presence of different extracellular matrix protein 
components in normal tissue, and once this was established, 
diseased liver was examined and the distribution patterns 
compared (Biagini and Ballardini, 1989). Collagen types 
which have been found in normal liver include types I, III 
and IV (Clement et al, 1985, Grimaud et al, 1980, Hahn et 
al, 1980, Voss, Rautenberg and Allam, 1980), V (Rojkind, 
Giambrone and Biempica, 1979; Schuppan et al, 1986) and VI 
(Von der Mark et al, 1984).
6.1.1 Methods used in previous studies
These studies used a range of techniques such as 
indirect immunofluorescence (Bianchi et al, 1984; Schuppan 
et al, 1986; Geerts et al, 1990), peroxidase-antiperoxidase 
(Martinez-Hernandez,1984; Clement et al, 1984) - both of
these techniques localised the protein; and in-situ 
hybridisation for localisation of mRNA (Milani et al, 1990; 
Yamada et al,1989). This can make a direct comparison of 
studies difficult as some of the techniques are more 
sensitive than others, and the distribution of mRNA for a
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protein may differ from that of the protein produced. In 
general, most interstitial collagens have a similar pattern 
of distribution in the normal liver, i.e they are found 
lining the sinusoids, in portal tracts and around hepatic 
veins (Schuppan, 1990). In diseased liver, interstitial 
collagens may also be present in any fibrotic septa. 
Basement membrane components, such as type IV collagen, 
laminin and heparan sulphate, are found around the hepatic 
veins and sinusoids (Hahn et al, 1980; Bianchi et al, 1984; 
Maher et al,1988). There is no evidence for laminin
within the space of Disse in normal liver using light 
microscopy although another component of the basement 
membrane, type IV collagen, was present. This changes 
during hepatic fibrosis, when laminin and type IV collagen 
are co-distributed in the space of Disse (Hahn et el, 1980, 
Rauterberg et al, 1981).
Once the tissue distribution has been determined, the 
next step is to identify the cells of origin of the hepatic 
extracellular matrix proteins. Using immunocytochemical 
techniques, the limited resolution of light microscopy 
techniques means that it can be difficult to determine the 
precise location of the cells responsible for the 
production of extracellular matrix components.
In-situ hybridisation techniques have recently been 
developed for use on frozen tissues, but these are not yet 
widely available ( Yamada et al, 1989; Milani et al, 1990). 
Studies by Milani et al describe the localisation of mRNA 
for collagen types I, III and IV in non-parenchymal cells 
of rat liver. This is in contrast to Yamada et al who
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identified mRNA for type III procollagen within hepatocytes, 
as well as mesenchymal cells of cirrhotic human liver.
In order to overcome the difficulties involved in 
identification of the cells responsible for hepatic 
extracellular matrix synthesis, several groups adapted 
immunocytochemical methods for use in electron microscopy.
6.2 Description of hepatic extracellular matrix 
protein ultrastructural studies.
Using ultrastructural post-embedding techniques, it 
was shown that in normal liver, all of the sinusoidal 
staining previously identified by light microscopy and 
immunocytochemistry was in fact localised to the space of 
Disse (Martinez-Hernandez, 1984). This used the
immunoperoxidase method to examine normal rat liver, but 
did not identify any intracellular labelling. In contrast, 
he was able to immunolocalise laminin within fat-storing 
cells in regenerating liver (1991). Clement et al (1988) 
used the same technique to examine human liver, and 
identified intracellular labelling of laminin in fat- 
storing cells as well as in vascular endothelial cells, 
bile duct cells and endothelial cells. They also examined 
fibrotic human liver and found laminin within hepatocytes.
A more complex relationship between the individual 
collagen types has recently been described with the 
discovery of collagen fibrils which were composed of more 
than one type of collagen (Henkel and Glanville, 1982; 
Geerts et al, 1990). The mixed fibrils of types I and
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Ill, or I and V, mean that the use of single antibodies to 
identify the collagen species present may give a misleading 
picture.
6.3 Hepatic extracellular matrix proteins produced in
tissue culture.
As all cells have the same genetic make up, they are 
all theoretically capable of synthesising matrix 
components. In practice however, cell types vary in both 
the type and the amount of matrix proteins that they 
produce. This is true of both in vivo, and in vitro
systems. One approach is to examine each of the cell
types individually, and this is most often done using 
tissue culture systems. The liver cells which have been 
studied in this way are hepatocytes, fat-storing cells, 
endothelial cells and Kupffer cells.
6.3.1 Cell isolation.
The first step in tissue culture is to isolate the 
individual cell types from the liver. The liver tissue is 
disrupted by perfusion with a solution of collagenase, 
giving a cell suspension. It is then necessary to
separate out the differential cell types, and this is done 
by centrifugation. If only non-parenchymal cells are
required, the hepatocytes can be removed with a pronase 
solution, and a mixture of non-parenchymal cells is left. 
This mixture of cells can be separated by density gradient 
centrifugation which isolates one cell type at a time 
(Friedman and Roll, 1987), or by centrifugal elutriation
60
which separates all the components in one step, giving 
individual fractions (Brouwer, Barelds and Knook, 1984). 
Once the cells have been isolated, the homogeneity of the 
population must be determined by examining morphological or 
biochemical characteristics.
6.3.2 Cell culture techniques.
The regulation of cellular collagen synthesis can be 
manipulated by the choice of substrate. Most of the
earlier studies used tissue culture plastic as the
substrate whereas in later studies the plastic culture
dishes were coated with collagen type I, type IV or with
basement membrane components isolated from the Engelbreth- 
Holm-Swarm sarcoma (Bissell et al,1987; Bucher, 1990).
6.3.3. In vitro assays.
This approach, has both advantages and drawbacks. 
Pure populations of each cell type can be examined and the 
regulation of extracellular matrix protein synthesis 
examined by the manipulation of the cellular environment. 
It is also possible to compare the extracellular matrix 
protein synthesis of the different cell types under 
similar, but not identical, conditions. This can help to 
identify the major extracellular matrix protein producers. 
As well as individual populations, co-cultures can also be 
used, or cells can be treated with medium conditioned by 
other cell types in order to examine the possible 
relationships found in vivo (Meyer, Bachem and Gressner, 
1990) .
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6.4 Extracellular matrix protein synthesis.
Early tissue culture studies of extracellular matrix 
protein production examined collagen synthesis in 
hepatocytes (Bissell and Guzelian, 1980). Since then,
other cell types, such as fat-storing cells have been 
examined (DeLeeuw et al, 1984). This showed that several 
different cell types synthesise the extracellular matrix, 
and it is not simply a case of identifying the one cell 
type which is responsible for hepatic extracellular matrix 
synthesis. If the relationship between the cell types is 
disturbed, alterations in the amount and composition of the 
extracellular matrix may occur.
6.4.1 Hepatocytes.
Hepatocytes were the first liver cells to be 
successfully cultured. Hepatocytes are the most abundant 
cell type in the liver, and it would not require a high 
level of collagen synthesis from individual cells to 
produce the amount of collagen required for physiological 
processes. Studies by Maher et al (1988) suggested that 
although hepatocytes were capable of synthesising collagen 
under cell culture, much of the collagen synthesis observed 
was in fact due to contamination of the hepatocyte cultures 
by fat-storing cells
Another approach to identifying the collagen producing 
cells was to isolate hepatocytes and look for messenger RNA 
within the cells. Saber et al (1983) reported that mRNA 
for collagen was detectable in hepatocytes. Recently,
Milani et al (1989,1990) used in-situ hybridisation to 
identify collagen producing cells in the rat liver, but 
could not detect any mRNA for laminin or collagen types I, 
III, or IV within hepatocytes. When Maher and McGuire
measured the level of type I collagen in the hepatocytes of 
C Cl4 treated rats, there was less than a two-fold 
increase in the mRNA in the stimulated cells as measured by 
Northern blot analysis.
The proteoglycan produced by hepatocytes is mainly in 
the form of heparan sulphate, and is usually cell- 
associated (Gressner and Schafer 1989). Cultured
hepatocytes produce laminin as well as large amounts of 
plasma fibronectin (Clement et al, 1986; Clement et al, 
1988)
6.4.2 Fat-storing cells.
In 1985, Friedman et al described fat-storing cells 
(lipocytes) as the main source of collagen in normal liver. 
When fat-storing cells are initially cultured, they are 
"normal" or "quiescent" and are similar to normal hepatic 
fat-storing cells. When these cells are cultured for any 
length of time on uncoated plastic, they become "activated" 
(Geerts et al, 1989). During this process, they lose
their characteristic lipid droplets and become more 
fibroblast-like (Callea and Desmet, 1985). This
corresponds with the transitional cells found in fibrotic 
liver (Mak and Lieber, 1988). In culture, activated fat- 
storing cells display increased levels of collagen
synthesis.
Fat-storing cells are very sensitive to their culture 
substrate. If fat-storing cells are maintained on EHS 
extract, they are non-proliferative (quiescent) and 
maintain a compact appearance. The cells have low levels 
of collagen synthesis and the collagen produced is mainly 
type III. In comparison, fat-storing cells which are 
maintained on plastic or type I collagen spread out on the 
substrate, proliferate and synthesise large amounts of type 
I collagen (Friedman et al, 1989; Senoo et al, 1986; Weiner 
et al, 1990). This activation of fat-storing cells occurs 
after several days of culture. These results suggest that 
in order to obtain data on matrix production of fat-storing 
cells, it is advisable to use early cultures, or cultures 
grown on basement membranes. As well as type I and type 
III collagen, fat-storing cells can also produce type IV 
collagen.
Fat-storing cells also synthesise large amounts of 
proteoglycans, up to six times that of hepatocytes (Arenson 
et al, 1988). The majority of this is dermatan or
chondroitin sulphate, which may be involved in collagen 
fibrillogenesis (Witsch et al, 1990). Gressner and
Haarmann (1988) showed that fat-storing cells also 
synthesise hyaluronic acid. Primary cultures of fat-
storing cells produce both fibronectin and laminin in 
considerable quantities (Ramadori et al, 1987; Maher et al, 
1988), as well as tenascin (De Bleser et al, 1991). The 
amount produced increases as the cells become activated.
The ability of the fat-storing cell to synthesise the 
components of the extracellular matrix, especially when it
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is in the activated state, is consistent with its proposed 
role as the major cell type involved in hepatic fibrosis.
6.4.3 Endothelial cells.
The endothelial cells produce relatively small amounts 
of collagen, which Irving et al (1985) identified as type 
IV collagen. This is consistent with the proposed role of 
endothelial cells in the deposition of a sub-endothelial 
matrix which forms an atypical basement membrane. In
contrast, endothelial cells produce large amounts of non- 
collagenous matrix proteins. Cultured endothelial cells 
produce the cellular form of fibronectin (Rieder et al 
1987; Clement et al, 1986), and this has been demonstrated 
by immunocytochemistry as well as by cell culture. The 
other major basement membrane glycoprotein is laminin, 
which both Maher and McGuire ,(1990), and Tsutsumi et al 
(1988) identified in cultured endothelial cells. Laminin 
mRNA has also been found in endothelial cells by Milani et 
al (1989).
6.4.4 Kupffer cells
To date, no collagen production has been identified 
in these cells by any method. Their role in collagen 
production apppears to be limited to the production of 
soluble factors which act as fibrogenic mediators. These 
factors activate fat-storing cells in cell cultures and in 
fibrotic liver (Friedman 1990). Like all other
macrophages, Kupffer cells synthesise fibronectin
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(Tsukamoto 1981) and also have fibronectin surface 
receptors which play a part in phagocytosis.
Due to the complex relationships between the 
individual cell types found in the liver, the examination 
of cell cultures in vivo yields limited information 
regarding the synthesis of extracellular matrix proteins. 
The results are further complicated by the effects of the 
tissue culture substrate used. Results obtained by these 
methods must be regarded with caution. As this is an in 
vitro system the results cannot always be extrapolated to 
an in vivo situation, where there are far more factors 
involved. With an in vivo situation, there are complex 
interactions between different cell types, which can rarely 
be duplicated exactly in an in vitro model. These
interactions result in the release of growth factors and 
other mediators such as TGFfl, which affect the synthesis of 
extracellular matrix proteins. The use of an in vitro 
system defines the extracellular matrix proteins which the 
individual cell types are capable of producing under 
certain circumstances, while an in vivo system identifies 
the components which are being manufactured in the tissue 
by a range of cell types. This means that in vivo
techniques are of limited use in examining the synthesis of 
extracellular matrix proteins.
6.5 Overall knowledge of hepatic extracellular matrix 
proteins.
The distribution of some components of the 
extracellular matrix proteins have been well established,
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while others have not been studied in detail. The major 
collagen components are type I and type III, which make up 
> 80% of the total collagen content (Schuppan, 1990) in
both normal and cirrhotic liver. Type I is mainly
localised in the portal tracts, around terminal hepatic 
veins and in Glissons capsule, with some type I collagen 
present in the space of Disse where it helps form a 
scaffold throughout the liver. Type III has a similar 
distribution to that of type I, but it is more abundant 
(Voss, Rauterberg, Allam et al, 1980; Rauterberg et al, 
1981) .
The distribution of these two collagens has been 
examined in a number of studies (Schuppan et al, 1990) and 
it is now known that one of the the major alterations in 
fibrotic liver is in the ratio of the two collagens. In
normal liver the ratio of type I:type III is 1:1, and in 
cirrhotic liver this increases to 3:1 (Seyer et al, 1977; 
Rojkind et al, 1979). In early stages of fibrosis it is 
type III which is the predominant collagen.
The interstitial collagens which are known to be 
present in the liver include type V collagen which was 
found in the portal tracts, and surrounding hepatic veins. 
It appears to co-localise with type I and III collagen in
normal liver, and it is known that they can form hybrid
fibrils. In cirrhotic liver, the absolute and relative 
amount of type V collagen is greatly increased (Rojkind, 
Giambrone and Biempica, 1979). This results in the
hepatocytes being encased in a layer of type V collagen.
67
Type VI collagen is also found in normal liver (Von der 
Mark et al 1984) .
The components of the basement membrane have also been 
examined, especially type IV collagen and laminin. 
Basement membranes are found around the hepatic arteries, 
portal veins, lymphatic vessels, bile ducts and nerve axons 
(Vracko, 1982).
Fibronectin is found around portal tracts and hepatic 
veins, as well as in the space of Disse (Schuppan, 1988) . 
The fibronectin can be associated with basement membranes, 
or with the interstitial collagens (Geerts et al, 1986). 
It has also been found in the space of Disse unattached to 
ant other ECM components, where it appears as an amorphous 
clump.
Other components of the extracellular matrix which are 
known to be present in liver are undulin,
glycosaminoglycans and thrombospondin.
6.6 Aspects of hepatic extracellular matrix proteins yet 
to be studied.
At the commencement of this study, the abundant 
interstitial collagens which were first identified had been 
used in many tissue localization studies, including liver. 
In contrast, the hepatic distribution of novel collagens 
such as type VI have not been studied in detail (Von der 
Mark, 1984).
Few localisation studies have been extended to include 
ultrastructural aspects, and this imposed certain 
limitations. In order to identify the cells of origin of
the hepatic extracellular matrix proteins by in vitro 
methods, it is necessary to identify the different 
sinusoidal cells. This can done most accurately with
electron microscopy techniques.
Previous studies of hepatic extracellular matrix have 
concentrated on the distribution of the most common ECM 
components, and the majority of the studies used normal 
human liver.
As it was impractical to examine all of the 
extracellular matrix proteins components in detail, the 
first stage of this study was to choose which components of 
the extracellular matrix were to be used. As the bulk of 
the hepatic extracellular matrix proteins consists of 
collagen, we decided to examine collagen types I, III, IV, 
V and VI. This allowed us to examine both interstitial 
and basement membrane collagens in detail. The study of 
types I, III and IV allowed comparison with previous work 
using a wide range of methods, while the distribution of 
types V and VI had not been examined in detail before now.
As well as collagen, we examined other extracellular 
matrix proteins, in particular, fibronectin, laminin and 
undulin.
It was possible to use similar techniques for both 
light microscopy and ultrastructural studies, thus 
maximising the small amounts of tissue which were 
available. The deposition of extracellular matrix protein 
components can be detected by immunocytochemical 
techniques, in order to identify the pattern of the 
extracellular matrix within the liver. Using the tissue
which was prepared for ultrastructural studies, it should 
be possible to detect intracellular labelling. This would 
identify the cells which are synthesising and secreting the 
extracellular matrix proteins.
6.7 Aims of this study.
This study was intended to examine two main aspects of 
the hepatic extracellular matrix.
1. To localise a number of the hepatic extracellular matrix 
proteins components at both light microscopic and 
ultrastructural levels.
2. To identify the cell types which were responsible for 
the production of these components in normal and fibrotic 
liver.
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7 .1______Immunocytochemistry
Immunocytochemistry has been defined as the use of
labelled antibodies as specific reagents for the detection 
of tissue constituents or antigens "in situ" (Polak and Van 
Noorden, 1987). Labelling can be carried out on specimens 
prepared in various ways, and many different labels can be 
used, but there are some requirements which should be 
fulfilled for optimal immunolocalisation.
1. The antibodies to be used (either polyclonal or
monoclonal) should be specific for the antigen which is to
be identified.
2. All epitopes should be accessible to the antibody and 
secondary label.
3. The antigen should be minimally altered by any fixative 
used.
4. The original morphology should be preserved whenever 
possible.
The first immunocytochemical studies of the 
extracellular matrix were carried out on 3^m sections of
tissue, which were either unfixed frozen sections, or 
paraffin-embedded,fixed material. The antibodies were
visualised by any one of a number of systems, including 
indirect immunofluorescence, peroxidase-antiperoxidase and 
alkaline phosphatase. These were mostly "sandwich"
techniques, and were only of limited use in the 
localisation of extracellular matrix proteins (Fig 7.1).
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The use of unfixed frozen tissue gave poor morphology, 
and made identification of individual cell types difficult. 
While the use of fixed, embedded tissue gave better 
morphology, it was still limited, mainly by the fact that 
the antibodies can only penetrate the upper part of the 
section.(Stirling, 1990)
The different second layer systems all had their own 
advantages and disadvantages. Indirect immunofluorescence 
gave a strong signal which was suitable for photography, 
but it was not permanent and the tissue morphology was 
difficult to examine when normal illumination was used as 
the sections were lightly fixed and not counterstained. 
The avidin-biotin labelling system was difficult to use in 
the liver, as there are large amounts of endogenous biotin 
liver. It is possible to block endogenous biotin in the 
liver before immunocytochemistry is carried out. This
involves blocking the biotin within the section with avidin 
or streptavidin before using biotinylated antibodies. In 
a similar manner, any endogenous peroxidase can be blocked 
with methanol/hydrogen peroxide to allow peroxidase/anti­
peroxidase labelling techniques The use of enzymes such 
as peroxidase and alkaline phosphatase give good labelling 
of extracellular tissue components, but have limited use in 
studying the intracellular components as there can be 
difficulties in identifying the labelled cells at the light 
level.
One solution to both of these problems is to use 
immuno-electron microscopy. This technique uses very thin 
sections of tissue, which require less penetration, and
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also gives better resolution. Identification of
intracellular labelling may allow identification of the 
individual cells which are producing the extracellular 
matrix.
7.2. The electron microscope
The limit of resolution of a microscope is determined 
by the wavelength of the energy source, and this limit can 
be increased by using an electron beam instead of light. 
Problems of specimen preparation and radiation damage 
effectively limit the resolution to 2nm.
There are two main types of electron microscopy and 
these are transmission (TEM) and scanning (SEM). With 
transmission electron microscopes, the tissue is cut into 
ultrathin sections, which can be examined in the microscope 
as transverse sections. All the specimens used in this 
study were examined by transmission electron microscopy.
7.3 Specimen preparation
In order to study ultrathin sections of biological 
material in the electron microscope, careful specimen 
preparation is required. There are several problems
unique to electron microscopy, and special fixation, 
embedding, cutting and staining techniques have been 
developed.
The first critical step is to obtain and fix the 
tissue, in order to maintain the original structure and 
protect the tissue from further damage during processing. 
The specimen must be fixed as soon as possible. For
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successful fixation the tissue blocks must be small enough 
to allow penetration throughout the entire tissue. It is 
critical to choose a suitable fixative. This consists of a 
fixing agent in a vehicle (usually a buffered salt 
solution). The vehicle must be of physiological
osmolarity (or higher) and ionic constitution for the 
tissue and be able to maintain a constant pH during 
fixation, in order to prevent the cells from shrinking and 
disrupting the tissue. Fixatives suitable for light
microscopy are not necessarily useful for electron 
microscopy, as they may not prevent damage to the tissue 
which is only apparent at the ultrastructural level.
For many biological specimens, two fixatives are used. 
The primary fixative is usually an aldehyde 
glutaraldehyde, paraformaldehyde or a mixture of the two. 
Paraformaldehyde has a higher rate of penetration, but the 
reaction with tissue proteins is slow and reversible. 
Glutaraldehyde reacts very rapidly with proteins and cross­
links them before any significant extraction of cytoplasmic 
components can occur. There is no significant fixation of 
the lipid component or membranes in the tissue, and there 
is no contrast in the tissue when viewed in the electron 
microscope. For secondary fixation an aqueous solution 
of osmium tetroxide is normally used to fix lipids and 
proteins. As this is electron dense, it contributes to 
the staining of the tissue.
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7.4 Embedding tissue in resin.
Once fixation for transmission electron microscopy 
has been completed, it is necessary to embed the tissue in 
a support medium in order to cut ultrathin sections. 
Paraffin wax is far too soft for this, and new resins were 
developed for ultramicrotomy. Most of these resins are 
water-immiscible, and the tissue must be rinsed in buffer 
to remove excess fixative, then dehydrated in alcohol or 
acetone. The tissue is then infiltrated with the liquid 
resin, placed in capsules and the resin is polymerised. 
Polymerisation may be induced by heat or ultraviolet 
irradiation.
7.5 Sectioning of resin embedded tissue
Factors determining the quality of the sections such 
as the embedding material, block trimming, quality of the 
knife and the cutting speed will be briefly discussed here. 
The resin used determines the plasticity and cutting 
characteristics of the block.
Although knives can be made from sapphire or diamond, 
the majority of ultrasectioning is carried out with glass 
knives. These are usually made immediately prior to 
sectioning. With the introduction of commercial knife- 
making machines, it is possible to make knives of 
reproducible quality. Glass is broken to produce a
perfect square, which is then broken diagonally to produce 
two knives with a cutting edge of 45° (Griffiths et al, 
1983). The quality of the knives can be determined by
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examination in the ultramicrotome, and the best area for 
sectioning chosen.
The trimmed block is placed in the ultramicrotome and 
ribbons of sections of approximately lOOnm thickness are 
cut at slow speeds (<lmm/sec) to prevent excess vibration. 
The ribbons of ultrathin sections are collected on either 
copper, nickel or gold grids and these are left to dry 
before they are stained.
7.6 Staining for transmission electron microscopy.
Sections of biological materials lack contrast when
they are examined in the electron microscope. This is 
partially overcome by secondary fixation with osmium 
tetroxide before resin embedding, and staining of the 
ultrathin sections with a combination of heavy metal salts, 
such as uranyl acetate followed by lead citrate. The use 
of secondary fixatives increases the amount of cross 
linking in the tissue specimens. This can affect the
accessibility of tissue antigens: the use of secondary
fixatives is therefore not always suitable for tissues 
which are to be immunolabelled.
7.7 Ultracryomicrotomy : Advantages for immunolocalisation
studies
Immunocytocytochemical studies can be performed with 
ultrathin sections obtained by the above methods (Beesley, 
1989; Stirling, 1990). The limiting factor is
preservation of the antigen of interest. During the
fixation and embedding, the tissue is treated with a wide
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range of chemicals, some of which may damage the antigens 
present to such an extent that they cannot be identified by 
conventional immunocytochemical methods. In order to
overcome this problem new resins were developed, which did 
not require the complete dehydration of the tissue by 100% 
alcohol, and which could be polymerised at lower 
temperatures with the use of ultraviolet light. Several 
such resins are now available, and include L.R.White, 
L.R.Gold and Lowicryl. Although these resins provide an
excellent embedding medium for immunocytochemical studies 
of a number of antigens, some are so sensitive to chemical 
treatment that they cannot withstand even this degree of 
processing. An alternative technique was developed to 
overcome these difficulties (Bernhard, 1965, Tokayasu, 
1973). Instead of using a synthetic embedding material, 
tissue was briefly fixed in low concentrations of fixative 
and then frozen in small blocks. The frozen tissue could 
be cut in a specially adapted ultramicrotome, and then 
immunolabelled in the same way as for resin embedded 
material. This approach was facilitated by the use of a a 
cryoprotectant which prevented damage by ice-crystal 
formation during freezing (Skaer, 1977).
7.8 Development of ultracryomicrotomy
The first attempts at ultracryomicrotomy involved 
placing conventional ultramicrotomes into a deep freezer 
(Bernhard, 1965). Using this approach, it was difficult to 
change the temperature, limiting the types of material 
which could be cut as there is an optimum temperature for
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ultracryomicrotomy of each tissue. This arrangement was 
also impossible for personnel to use for prolonged periods. 
Soon after this, cryochamber attachments for conventional 
ultramicrotomes were designed which used an insulated "box" 
or cryochamber around the knife stage and specimen arm of 
the ultramicrotome. Most of these attachments use the 
Christensen design, where the specimen arm traverses the
wall of the cryo-enclosure with an insulated U-shaped 
bridge (Christensen, 1971). Only the area within the
cryochamber is cooled - an economical method when compared 
to a cryostat. The temperature of the knife and specimen 
can be regulated independently of each other , and the 
chamber temperature can also be regulated. All of the
cutting controls operate at room temperature and are thus 
more reliable.
All the ultracryomicrotomy described here was carried 
out using the Reichert Jung FC4D attachment for the 
Ultracut E ultramicrotome.
Once the specimen is frozen it is essential to use a 
good knife. Glass knives are normally used (Griffiths 
(1984); Stang (1988)), although some diamond and sapphire 
knives are specially designed for use at low temperatures. 
The hardness of the tissue block can be varied by altering 
the concentration of the cryoprotectant, and the sectioning 
temperature. Sucrose, one of the most common
cryoprotectants, is normally used in the concentration
range 1. 2M to 2.6M. The lower the concentration, the
lower the temperature required for sectioning, and the 
harder and more brittle the block. The concentration
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used depends on the type of tissue to be cut, and must be 
determined for each tissue. The cutting speeds required 
for this method are usually slow (<lmm/sec), to prevent 
chatter and energy transfer to the specimen, and the 
sections are approximately lOOnm thick.
At this stage it is possible to determine the amount 
of ice-crystal formation which has occurred during the 
freezing stage. If there has been a lot of ice-crystal
formation the sections will be white and crumbly. Well 
frozen sections will be clear and cellophane like. 
Sections of approximately 90nm thickness will be blue/green 
in appearance-. These sections are then transferred to a
grid and used for immunocytochemical studies.
7.9 Preparation of tissue for immunocytochemistry.
The two main approaches to ultrastructural 
immunocytochemistry involve either pre-embedding or post­
embedding labelling of tissues.
a) Pre-embedding labelling
This involves permeabilization of aldehyde fixed cells or 
tissues with polar solvents or detergents. The
permeabilized structures are then exposed to the primary 
antibody and the secondary marker, refixed and processed 
for conventional resin embedding and sectioning. The 
secondary marker should be a substance which is electron- 
dense, i.e. it will show up as a dark area when examined 
under the electron beam. This method is particularly
suitable for studying cell suspensions rather than tissue
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blocks and has been used successfully to identify antigens 
on the outer membranes of cells or micro-organisms 
(Beesley, 1989), but it is not particularly suitable for 
the localisation of intra-cellular structures (Stirling, 
1990) . As this study aimed to identify both the cells 
responsible for the production of extracellular matrix 
proteins and the pattern of matrix protein deposition 
within the liver, the usefulness of pre-embedding labelling 
was very limited.
b) Post-embedding labelling
There are several variations of this method. 
Conventional Epon embedding can be used as discussed above, 
but the sensitivity is reduced due to the loss of antigen 
during dehydration and embedding (Beesley, 1989). There 
may also be a high degree of non-specific binding to the 
resin itself. Some of these problems can be at least 
partially overcome using hydrophilic resins such as
L.R.White, and which do not require total dehydration of 
the tissue (Newman, Jasani and Williams, 1983). Low
temperature resins such as Lowicryl have also been
developed (Carlemalm, Garavito and Villiger, 1982), which 
preserve the morphology while greatly improving the 
sensitivity. The newest post-embedding technique is to
use thawed ultra-thin cryosections (Tokuyasu, 1973, 1986). 
Using this system does have several disadvantages. The 
blocks have to be stored in liquid nitrogen, and the
maximum storage time of the frozen blocks has not yet been 
determined. The tissue has to be obtained fresh and the
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fixative carefully chosen (Burt et al, 1990; Griffiths, 
Keir and Burt, 1991), and most archival material which may 
have been frozen cannot therefore be used.
Pre-embedding techniques were not suitable as 
discussed above, but in the early stages of this study 
post-embedding labelling using tissue embedded in LR White 
and LR Gold was tried. The degree of labelling obtained 
was very low, even with extracellular matrix components 
which were present in large amounts such as collagen types 
I and III. As a result the rest of the study concentrated 
on ultracryomicrotomy. The technique was adapted from
that described by Geerts et al (1889) using rat liver. 
Different fixation regimes were used, and polyvinyl alcohol 
was used for the post-labelling embedding of sections 
rather than methyl cellulose. This allowed better
visualisation of the sections and also improved the 
stability of the tissue sections.
7.9.1 Primary antibody layer
The antibody can be against one epitope of the antigen 
(monoclonal), or against a range of epitopes (polyclonal). 
The tissue is incubated with non-immune serum in order to 
block any non-specific binding of antibodies, then a range 
of antibody dilutions are applied to tissue sections to 
determine the optimum conditions for labelling. The
antibodies are left on overnight at 4°C or at room 
temperature for several hours. Any unbound antibodies are 
then washed off, and the bound antibodies are visualised.
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7.9.2 Visualisation of antigens.
There are a wide range of labelling systems currently 
used for immunocytochemistry, but the most common marker 
used for ultrastructural immunocytochemistry is colloidal 
gold. This is a spherical electron-dense marker which can 
be conjugated to many different labelling systems including 
the following -
Label Target
Enzymes
(e.g.
alkaline phosphatase)
Specific enzyme substrates. 
(NBT/BCIP)
Enzymes
(e.g. peroxidase)
Antibodies to enzyme 
(peroxidase-antiperoxidase)
Lectins A specific sequence of sugar 
residues (no requirement for 
antibody).
Streptavidin Biotinylated primary 
antibodies
Protein A Immunoglobulin
(e.g. primary antibody)
Protein G Immunoglobulin
(e.g. primary antibody)
Antibodies Primary antibody from a 
different species.
Table 7.1 Labelling systems for immunocytochemistry.
The majority of the labelling in this study used 
protein A-gold linked to the detection system, with a 
minority of experiments using IgG-gold. Protein A-gold 
can be applied to antibodies from a wide range of species 
(table 7.2), and reacts with the antibody in a 1:1 ratio. 
This allows quantitative studies, but is a disadvantage if
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signal amplification is required. The gold particles form 
perfect spheres and can easily be identified in sections of 
biological material. The size of the sphere can be
altered to suit the procedure. This is in contrast to the 
other major ultrastructural immunolabelling technique, 
peroxidase-antiperoxidase labelling (PAP). The PAP label 
appears as a diffuse and slightly fuzzy particle. It is 
not possible to alter the size of the complex. Despite 
these difficulties, some groups have claimed that it is a 
more sensitive technique and prefer it to immunogold. 
Immunogold labelling was chosen for this study because of 
its clear labelling and acceptable sensitivity.
The efficiency of protein A as a secondary system 
varies between species (table 7.2). Protein A-gold has 
been reported to have low sensitivity for goat antibodies, 
and in part of this study, rabbit anti-goat immunoglobulin 
conjugated to gold particles was used as a labelling 
system.
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SPECIES IgG SUBCLASS PROTEIN A
MAN IgGl +++
IgG2 +++
IgG3 +/-
IgG4 +++
IgA + /-
IgM +
IgD -
GOAT ig +/-
RABBIT ig
TABLE 7.1 Affinity of immunoglobulin subclasses with
protein A
+++ Strong affinity 
+ Poor affinity
± Very weak affinity
No affinity
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8.1. Sources of human tissue
All biopsies were obtained at either the Western
Infirmary or Gartnavel General Hospital, Glasgow. As
specific fixation regimes were required, it was not
possible to use archival material for any of the electron
microscopy studies. Some archival material was used for
the light microscopy studies and this was obtained from the
files of the Western Infirmary. This material had been
collected from patients undergoing investigation for liver
disease.Some of the PBC biopsies were obtained from the 
Royal Victoria Infirmary, Newcastle-Upon-Tyne.
8.1.1. Diagnostic needle biopsies.
All diagnostic biopsies were carried out using either 
the Menghini needle or the Tru-cut needle technique. The 
majority of the biopsy was fixed in 10% buffered formalin 
and used for routine histopathology. The remainder of the 
biopsy was split into small pieces (approx 2mm xlmm) and 
placed in one of three different fixatives.
i) 2% paraformaldehyde
ii) 2% paraformaldehyde with 0.1% glutaraldehyde
iii) 2% glutaraldehyde
The fixatives used were prepared in 0.1 M phosphate 
buffer. The paraformaldehyde buffers were stored frozen 
and thawed imediately prior to use, and the glutaraldehyde 
was freshly prepared.
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8.1.2. Wedge biopsies of normal liver (n=15)
Wedges of liver were removed from cadaveric renal 
transplant donors. Whenever possible, the liver was
perfused with buffer through surface vessels immediately 
after removal, in order to remove blood from the sinusoids,
and to prevent collapse of the sinusoids. Once the tissue
had been sufficiently perfused, it was cut into smaller 
pieces (lxlmm for EM, 2x2cm for light microscopy) and 
immersion fixed in either formalin (light microscopy) or 
one of the EM fixatives previously described.
8.1.3 Liver resections (n=5)
These were obtained from patients with hepatic
tumours. When the liver was resected, a section of liver 
which was tumour-free by gross examination was removed by 
wedge biopsy and placed in fixative (as above). Sections 
of this tissue were examined to confirm the absence of any 
significant abnormality.
8.1.4. Diagnosis of liver disease.
All biopsies in this study were examined by Professor 
RNM MacSween and Dr AD Burt in the Pathology department of 
the Western Infirmary. The diagnoses are summarised in 
table 8.1.
8.2 Processing of biopsies for light microscopy
After overnight fixation, the biopsies were processed 
through graded alcohols to paraffin wax in a VIP tissue 
processor, and embedded in individual blocks before
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DIAGNOSIS NUMBER OF CASES
NORMAL x 20
NON-SPECIFIC HEPATITIS 10
ALCOHOLIC LIVER DISEASE 7
PRIMARY BILIARY CIRRHOSIS 6
CRYPTOGENIC CIRRHOSIS 5
NODULAR REGENERATIVE HYPERPLASIA 4
METASTATIC TUMOUR 3
PRIMARY SCLEROSING CHOLANGITIS 3
CHRONIC ACTIVE HEPATITIS 3
NON A - NON B HEPATITIS 3
STEATOSIS 2
SPACE OCCUPYING LESION 2
PRIMARY BILIARY CIRRHOSIS/
CHRONIC ACTIVE HEPATITIS 2
GRANULOMA 1
HEPATITIS A 1
HEPATITIS B 1
CROHNS DISEASE 1
HAIRY CELL LEUKAEMIA 1
PANCREATITIS 1
CHOLESTASIS 1
CHOLANGITIS 1
SIDEROSIS 1
TOTAL NUMBER 81
TABLE 8.1 Biopsies used in this study
1 Includes cadaveric transplant donors.
sectioning. Five micron thick sections were placed on 
poly-L-lysine coated slides for further staining.
8.3 Processing of biopsies for electron microscopy
The method used for processing the liver biopsies for 
electron microscopy depended on whether it was to be used 
for morphology or immunocytochemistry.
8.3.1 Processing for routine TEM
The tissue was fixed in 2% glutaraldehyde and 
embedded in araldite resin (see appendix B). The
polymerised blocks were then trimmed before cutting in a 
Reichert-Jung ultramicrotome. Semi-thin sections (2pm)
were stained with toluidine blue and the area of interest 
was chosen for ultrasectioning. After further trimming, 
lOOnm thick sections were cut and placed on copper grids 
(100 mesh, Agar Scientific, England). All grids were
stained with uranyl acetate and lead citrate (see appendix 
C) and viewed in a Philips CM10 transmission electron 
microscope.
8.3.2 Processing for immunocytochemistry
When the tissue was used for ultrastructural 
immunocytochemistry, two different methods were tested.
A. LR White embedding.
Blocks of tissue (0.5mm2) were immersion fixed in 2% 
paraformaldehyde ± 0.1% glutaraldehyde fo^ several hours
before dehydration through graded alcohols. The block was 
immersed in a 1:1 mixture of ethanol and LR White resin for
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1 hour then placed in LR White resin for 1 hour. The
tissue was then placed in a mould containing fresh LR White 
resin. The block was cured overnight in an anaerobic
chamber at 55°C. Sections were cut on a conventional
microtome and placed on formvar-coated nickel grids (Agar 
Scientific, England).
B. Ultracryomicrotomy.
Blocks of tissue (0.5mm2) were immersion fixed in 2%
paraformaldehyde ± 0.1% glutaraldehyde for several hours,
before saturation with 2.3M sucrose. The blocks were
placed on aluminium stubs (Reichart, Germany) and plunge
frozen in liquid nitrogen before storage in liquid 
nitrogen. The frozen blocks were then trimmed and cut in 
a Reichert-Jung FC4D ultracryomicrotome, using a dry glass 
knife as described above. Sections were removed with a 
wire loop containing saturated sucrose and transferred to 
carbon/formvar-coated copper grids (Agar Scientific, 
England) before being placed face down in PBS to remove the 
sucrose.
In the early stages of the study the biopsies were 
fixed in paraformaldehyde both with and without 
glutaraldehyde, and both the immunolabelling and morphology 
were compared. It was found that in most cases the
addition of 0.1% glutaraldehyde improved the morphology of 
the sections without affecting the immunolabelling. There 
were however some antibodies which did not immunolabel 
successfully in the presence of glutaraldehyde, and tissue
fixed in paraformaldehyde alone was used for these 
antibodies (see Chapter 9).
8 .4 Immunostaininq techniques
Although the same antibodies were used for 
investigation at the light and electron microscopic level, 
the methods used were different for each technique
8.4.1 Light microscopy
The first method was indirect immunofluorescence 
(IIF), using frozen sections of acetone-fixed tissue.
1. Sections were placed in 0.1M glycine\PBS for 3 x 5  
minutes to block any free aldehydes in the tissue, 
then incubated with 2% BSA\PBS for 15 minutes to 
block to any sites which could bind antibody in a 
non-specific manner.
2. Excess BSA was blotted off and lOOpl of the primary 
antibody was applied. The antibodies used are 
described in table 8.2. Primary antibody was diluted 
in 1:25 normal swine serum (NSS)/ phosphate buffered 
saline (PBS), with 0.1% saponin (a detergent which 
helps the antibody penetrate the section).
3. The sections were incubated at 37°C for 2 hours or at 
4°C overnight.
4. Sections rinsed in PBS (2x15 minutes).
5. Appropriate secondary antibodies (fluorescein 
isothiocyanate (FITC)-goat anti-rabbit or FITC rabbit 
anti-goat immunoglobulin, Hoescht, UK) were diluted 
1:50 in PBS/NSS and applied for 30 minutes at 37°C.
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6. Sections were thoroughly rinsed with PBS, then
mounted in Citifluor and examined in a Leitz Orthoplan 
microscope.
The second method used was peroxidase-antiperoxidase
(PAP).
1. 5/jm thick tissue sections were placed on poly L-lysine 
coated slides, and the sections were dewaxed in xylene 
before rehydrating in graded alcohols.
2. The tissue sections were incubated in 1.67% H202 \ 
methanol for 30 minutes to block any endogenous 
peroxidase present.
3. The sections were digested for 30 minutes at 37°C with
0.1% trypsin in tris buffered saline (TBS) containing
0.1% CaC03. This partially digests the tissue and 
helps expose the antigens present.
4. They were then rinsed with PBS and blocked with 1:5 
NSS:PBS to reduce background staining.
5. All the primary antibodies were diluted in 1:25 
NSS: PBS (see table 8.2) and lOOjil of antibody was 
applied to each slide before incubation at 4°C 
overnight in a moist chamber.
6. The sections were washed in PBS containing 1.8% NaCl 
for 30 minutes.
7. They were incubated for 30 minutes with the secondary 
antibody ( diluted in 1:25 NSS:PBS). This was either 
swine anti-rabbit (1:100) or rabbit anti-goat 
immunoglobulin (1:50) conjugated to horseradish 
peroxidase (Dakopatts, Denmark).
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8. The sections were rinsed with PBS, then incubated with 
peroxidase-antiperoxidase complex (PAP) for 30 
minutes.
9. The resulting complex was visualised with 0.5%
3'31diaminobenzidine tetrahydrochloride (DAB)/ 
methanol.
10. The sections were counterstained with Harris's 
haematoxylin, dehydrated, and mounted with Histamount.
8.4.2 Electron microscopy
Ultracryosections were cut as described in 8.3.2.
1. Sections were blocked with 1% immunoglobulin-free BSA 
(Sigma, UK) in PBS.
2. They were incubated at 4°C overnight with primary 
antibody diluted in 1% BSA\PBS (see table 8.2).
3. The grids were then washed several times in PBS.
4. The secondary antibody was diluted in 1% BSA\PBS and 
incubated for 2 hours at room temperature. (In most 
cases this was Protein A conjugated with gold 
particles of 5 or lOnm (Biocell,Wales) although goat 
anti-rabbit IgG or rabbit anti-goat IgG conjugated to 
gold were also used).
5. The sections were thoroughly rinsed with PBS and 
briefly rinsed with water.
6. Sections were lightly counterstained with 2% uranyl 
acetate before embedding in 2% uranyl acetate: 3% 
polyvinyl alcohol (10:1 v/v) and drying before 
examination in the electron microscope. In the early 
stages of this work, 1.3% methyl cellulose (Tylose,
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Fluka, Germany) was used but it was then found that 
polyvinyl alcohol gave a more even and stable film.
The extracellular matrix consists of many different 
components including hyaluronic acid. Immunolabelling for 
collagen types I, III and IV, gave far better results if 
the sections were pre-incubated with 150 units/ml 
hyaluronidase (Koch, Germany) for 30 minutes at 37°C to 
remove some of the hyaluronic acid which appeared to mask 
the antigens. This technique is similar to the use of 
trypsin for partial digestion of tissue prior to 
immunolabelling for light microscopy.
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ANTIGEN RAISED IN DILUTION
COLLAGEN TYPE I Rabbit 1 25
Pro COLLAGEN I Rabbit 1 80
COLLAGEN TYPE III Goat 1 50
Pro COLLAGEN III Rabbit 1 80
COLLAGEN TYPE IV Rabbit 1 100
TYPE IV (NCI region) Rabbit 1 50
TYPE IV (7s region) Goat 1 40
COLLAGEN V 2 Goat 1 50
COLLAGEN VI 1 Rabbit 1 160
FIBRONECTIN Rabbit 1 50
VITRONECTIN 2 Mouse 1 50
UNDULIN Rabbit 1 50
1
LAMININ Rabbit 1 100
LAMININ PI Rabbit 1 50
LAMININ 120 Rabbit 1 50
LAMININ 60 Rabbit 1 50
Table 8.2__________ Antibodies used in study
All antibodies were obtained from Dr D Schuppan, 
Free University of Berlin, except those marked.
1. Heyl, Germany
2. Sera laboratories, U.K.
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9.1. Immunocytochemistry at light microscopy level.
A total of 81 liver biopsies were obtained during this 
study, comprising 20 normal samples and 61 samples of 
diseased tissue. The range of diseases is outlined in 
table 8.1. While the indirect immunofluorescent technique 
was used initially to confirm the presence of extracellular 
matrix components in the tissue, the peroxidase- 
antiperoxidase (PAP) technique provided better resolution 
and more intense labelling. The majority of illustrations 
in this section will therefore be of antigens localised 
using the PAP technique. In some cases the immunostaining 
was improved if the sections were digested with trypsin 
before the antibody was applied, as this helped to break 
down the crosslinks formed during tissue fixation. Pre­
treatment with pepsin was also tested but this did not give 
any improvement and the use of detergents such as saponin 
as a pretreatment or in the buffers was also ineffective. 
In order to test the effectiveness of the different 
pretreatments, serial sections of normal liver were used. 
The different pretreatments were carried out and all of the 
sections were then immunostained under identical 
conditions. All of the slides were examined to see if 
there was improved immunolabelling in comparison with 
sections which had not been pre-treated. Similar
comparisons were used to determine the effectiveness of 
detergents in the buffer.
With some of the antibodies used in this study it was 
necessary to use tissue which was fixed in Bouins fixative
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or in paraformaldehyde. This is consistent with the study 
of Bedossa et al (1987) on immunolocalisation of collagen 
types I, III and IV in the liver. As all archive tissue 
was fixed in either buffered formalin or in formal 
sublimate, these antibodies could only be used on the wedge 
biopsies, where there was enough tissue to use a range of 
fixatives.
9.2 Collagen
Type I collagen. This component was evenly distributed
throughout the zones of the liver. It was present in the 
portal tracts, Glissons capsule, around terminal hepatic
veins, and in the space of Disse (Fig 9.1). Occasional
staining of hepatocytes was seen, but this was the only 
intracellular labelling for type I collagen. Labelled
hepatocytes were distributed randomly and were present in 
all zones. Type I could be immunolocalised in acetone- 
fixed frozen material or in fixed-tissue (paraformaldehyde, 
buffered formalin or Bouins fixative). Optimal labelling 
was obtained with Bouins fixed material.
Type III collagen. The distribution of type III collagen 
was similar to that of type I collagen, although the 
intensity of labelling within the space of Disse was often 
stronger. There was an even distribution throughout
different acinar zones in normal liver (Fig 9.2). Again, 
there was focal staining of hepatocytes staining with a 
similar pattern of distribution to that of type I collagen 
(Fig 9.3). Type III collagen could also be
immunolocalised in unfixed frozen material or in fixed 
tissue (paraformaldehyde, buffered formalin or Bouins 
fixative).
Type IV collagen. This was immunolocalised around blood 
vessels and bile ducts in portal tracts (Fig 9.4). It was 
also found within the space of Disse, in a linear 
distribution. There was no difference in the intensity of 
labelling within the different zones. The intensity of 
staining was dependent on the antibody used. Some of the 
antibodies available gave weak labelling (such as the 
antibody to the NCI region) and the strongest labelling 
was against the 7s component of type IV collagen. 
Although all the type IV antibodies worked on frozen or 
Bouins fixed material, only the anti-7s antibody gave 
labelling on material fixed in paraformaldehyde or buffered 
formalin. None of the antibodies gave intracellular
labelling.
Type V collagen. This collagen was present in the
space of Disse in a linear pattern. There was weak
staining in the portal tracts and stronger staining around
the hepatic vein. There was no zonal distribution and no
intracellular staining was seen (Fig 9.5). Staining was 
only observed in Bouins fixed material.
Type VI collagen. There was immunostaining for type VI
collagen in the space of Disse, with a linear pattern along 
the sinusoidal walls. Staining was weakest in the
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FIG 9.1
Distribution of type I collagen in normal liver
(peroxidase-antiperoxidase labelling).
Labelling is seen within the space of Disse for type 
I collagen, and more intensely around a terminal 
hepatic vein (THV).
FIG 9.2
Distribution of type I collagen in normal liver 
(peroxidase-antiperoxidase labelling).
Type I collagen is also found around the portal 
tracts (PT). This figure illustrates the even 
distribution of type I collagen throughout the 
liver.
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FIG 9.3
Distribution of type III collagen in normal liver,
(peroxidase-antiperoxidase labelling).
There is no zonal heterogeneity for type III 
collagen within the liver. It is found in the
space of Disse and around portal tracts (PT).
FIG 9.4
Distribution of type IV collagen in normal liver
(peroxidase-antiperoxidase labelling).
There are small amounts of type IV collagen present 
within
the space of Disse, but it is more intense around 
blood vessels. Weak labelling can be seen within 
portal tracts (PT).
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FIG 9.5
Distribution of type V collagen in normal liver
(peroxidase-antiperoxidase labelling).
Type V collagen is found in the space of Disse and 
around the terminal hepatic vein branches. There 
is no zonal heterogeneity.
FIG 9.6
Distribution of type VI collagen in normal liver 
(peroxidase-antiperoxidase labelling).
Although type VI collagen is found in the space of 
Disse and around blood vessels, the overall 
distribution has a zonal pattern. The area of 
weakest staining was always the periportal zone.
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periportal zone (zone 1) when compared to zones 2 and 3. 
This zonal heterogeneous distribution was found in all 
sections of normal liver. There was also immunolabelling 
in the portal tract stroma, around terminal hepatic veins 
and in Glisson's capsule (Fig 9.6). This was seen in both 
perfusion and immersion fixed tissues, and was not thought 
to be a staining artifact. At this level, it was
occasionally possible to detect some intracellular staining 
of sinusoidal cells with a stellate morphology. 
Hepatocytes were consistently negative.
9.3 Fibronectin. This was found in the space of Disse 
with a linear distribution and also in portal tracts and 
around terminal hepatic veins. The fibronectin was evenly 
distributed between the acinar zones. There was 
intracellular labelling in a number of hepatocytes and 
these were randomly distributed.
9 .4 Vitronectin. This could only be identified in
frozen sections. The distribution appeared to be similar 
to that of fibronectin, apart from the lack of any 
intracellular labelling. The antibody was not suitable 
for further studies.
9.5 Undulin. The staining obtained with this antibody 
were weak and inconsistent. Using Bouins fixed material 
it was possible to localise Undulin within the space of 
Disse and in portal tracts, but this antibody was not used 
for further studies.
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9 . 6 Laminin. The ability to identify laminin was
dependent on the fixative used (Table 10.1). The best 
results for all laminin antibodies were obtained with 
Bouins-fixed material. Laminin showed a similar
distribution to type IV collagen, with strong labelling 
around blood vessels and bile ducts. It was also possible 
to localise laminin within the space of Disse, although 
this labelling was less intense than that found around the 
blood vessels and bile ducts. Occasional intracellular 
staining was found in cells with morphology typical of fat- 
storing cells.
9.7 Immunocytochemistry at electron microscopy level.
The majority of the tissue used in this study was 
obtained from needle biopsies. The initial protocol
involved perfusing the biopsies with buffer via a very fine 
glass pipette in order to remove blood cells and to dilate 
the sinusoids before fixation. Although this gave small 
pieces of well perfused tissue, the damage caused at the 
immediate site of perfusion by both penetration of the 
glass pipette and pressure of the perfusate meant that only 
a small portion of the tissue was suitable for 
immunolabelling. As the biopsies were only a few
millimetres in size to start with, this meant an 
unacceptably high proportion of the tissue was lost. As a 
result of this the biopsies were immersion fixed for the 
remainder of the study. The morphology was still
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acceptable, and the pieces of tissue were small enough to 
allow even fixation throughout the entire biopsy.
In the preliminary stages of this study a number of 
different fixatives and embedding techniques were compared. 
Liver tissue which had been embedded in araldite resin gave 
excellent morphology but irrespective of the fixative used 
no positive staining was obtained. This suggested that 
the embedding procedure was either masking the antigenic 
sites or physically altering them, preventing recognition 
by the antibody. Etching the resin with periodic acid to 
remove the surface resin and prevent antigen masking did 
not result in any labelling. As a result of this, it was 
decided to use ultrathin frozen sections.
A range of sucrose concentrations from 1.3M to 3M were 
tested for use with liver biopsies (1.3M, 1.5M, 1.8M, 2M
and 2.3M) and the most successful concentration was found 
to be 2.3M. This was a similar concentration to that used 
by other groups (Tokuyasu, 1986). It prevented any damage 
and allowed the tissue to retain plasticity during 
sectioning.
Positive immunostaining with good morphology could be 
obtained with either 2% paraformaldehyde alone or 2% 
paraformaldehyde with 0.1% glutaraldehyde. If the
concentration of glutaraldehyde increased above this level 
the staining was rapidly lost. There was still an
unacceptably high level of non-specific or background 
staining and a number of different blocking techniques were 
tested in order to reduce the background staining. These 
included incubating sections face down on gelatin plates,
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incubating in 5% normal calf serum or incubating in 1% 
ovalbumin. The most effective agent was found to be the 
addition of 1% immunoglobulin free-bovine serum albumin 
(BSA). The sections were pre-incubated in this for 1 hour 
at room temperature or overnight at 4°C before 
immunolabelling and it was also used as the diluent for the 
antibody. The degree of background labelling was assessed 
by examining the control (diluent only, and diluent plus an 
appropriate serum) sections. Each individual staining run 
was only acceptable if the level of immunolabelling in 
these control sections was extremely low, and was evenly 
distributed over the section. If the amount of gold
labelling was high, or if clusters of gold were visible, 
the run was discarded.
When the sections were examined using light microscopy 
methods the immunolabelling was improved by pre-treatment 
with trypsin. In tissues fixed for immunolabelling with 
electron microscopy, trypsin is too harsh a treatment and 
an alternative had to be found. As many of the antigenic 
sites of the extracellular matrix are masked by an 
abundance of "ground substance" or hyaluronic acid, the 
effect of pre-incubating sections with hyaluronidase before 
immunolabelling was examined. Using this enzyme helped 
to remove background staining and increased the amount of 
specific labelling. The morphology of the tissue did not 
appear to be affected and the only minor difference seen 
was a small reduction in the amount of amorphous material 
in the extracellular spaces.
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The use of hyaluronidase only affected the labelling 
of extracellular areas and had no effect on intracellular 
labelling. In an attempt to improve intracellular
labelling, the ultrathin sections were either pretreated 
with 0.1% saponin or saponin was added to the antibody and 
wash buffers. This did not increase the amount of
intracellular labelling or improve the extracellular 
labelling and the use of saponin was discontinued.
When all of these different aspects of immunolabelling 
were examined, it was decided that the best fixative for 
use in this study was 2% paraformaldehyde with 0.1% 
glutaraldehyde. The morphology was poorer than that found 
in glutaraldehyde fixed material but the immunolabelling 
was far superior and this was the prime consideration. 
Unless otherwise stated all illustrations of 
ultrastructural immunocytochemistry are of tissue fixed in 
2% paraformaldehyde/0.1% glutaraldehyde.
Figure 9.7 illustrates the preservation of morphology 
using the adapted ultracryomicrotomy protocol. 
Membraneous structures such as the endoplasmic reticulum 
are well preserved and can clearly be identified. The 
vacuoles seen in the hepatocytes are believed to be due to 
the loss of glycogen rosettes.
In comparison with Figure 9.7, Figure 9.8 illustrates 
the morphology obtained when normal human liver is resin 
embedded. The boundaries of the space of Disse are clear 
and the collagen bundles within the space of Disse are 
easily identified by their striated appearance.
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FIG 9.7
Ultracryosection of normal human liver.
This shows the degree of preservation of 
morphological detail typical of sections obtained by 
ultracryomicrotomy. The membraneous structures
such as the endoplasmic reticulum are well preserved 
and easily identified, but some cytoplasmic 
components such as glycogen rosettes are lost. Mag 
x 7792
N - nucleus SD - space of Disse S - sinusoid
B.C. - bile canaliculus ER - endoplasmic reticulum 
H - hepatocyte
FIG 9.8
Resin embedded ultrasection of normal human liver.
In comparison with Fig 9.7 the glycogen rosettes can 
be seen in the cytoplasm. Collagen bundles can be 
seen within the space of Disse, and the fenestrated 
endothelial cells divide the sinusoid from the space 
of Disse. Mag x 32,000
G - glycogen S - sinusoid
EC - endothelial cell C - collagen
Figure 9.8
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9.8 Collagen
Type I collagen. Labelling for type I collagen was
identified on striated fibres within the space of Disse. 
This was most intense along the edges of bundles (Fig 9.9). 
The labelled bundles were often adjacent to fat-storing 
cells (Figure 9.11). There was also labelling within all 
portal tracts. As well as ordered bundles, there were 
also disorganised areas of collagen fibres; these may be 
newly synthesised fibres which have not yet formed bundles 
(Fig 9.10) .
Type III collagen Type III collagen was also found within 
the space of Disse (Fig 9.12) but the labelling was often 
more intense than that found for type I collagen (Figs 9.13 
and 9.14). The pattern of staining was even throughout 
the collagen bundles and was not concentrated at the 
margins as found with type I collagen (Figs 9.15, 9.16 and 
9.17). When the tissue was examined with antibodies to 
procollagen types I and III it was apparent that a far 
higher proportion of the type III collagen fibres retained 
the propeptide portion of the molecule after fibril 
formation in comparison with type I.
When fat-storing cells were identified, they were 
often surrounded by type III collagen bundles (Figs 9.18 
and 9.19). Despite the close proximity of the collagen 
bundles to the fat-storing cells intracellular labelling of 
the fat-storing cells was an extremely rare occurrence.
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FIG 9.9
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type I collagen. 
Heavy labelling for type I collagen can be seen on 
this collagen bundle. The labelling is
concentrated on the single fibres at the outer edges 
of the bundles, although there is some labelling 
throughout the entire bundle. Mag x 25,186 
SD - space of Disse H - hepatocyte
FIG 9.10
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type I collagen.
This area of partially disorganised striated 
collagen contains type I collagen. It is probably 
newly synthesised collagen which has not yet been 
organised into bundles as seen in the previous 
figure. The labelling is evenly distributed
throughout. Mag x 22,050
Nil»«
FIG 9.11
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type I collagen.
The collagen bundle adjacent to the fat-storing cell 
contains type I collagen. There is labelling
around the cell and within the space of Disse, but 
there is no intracellular labelling in the fat- 
storing cell.
Mag x 19,500
FSC - Fat-storing cell
SD - space of Disse
FIG 9.12
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
This is a loosely associated bundle of collagen 
within the space of Disse. The labelling for type 
III collagen is evenly distributed across the 
bundle. There is no intracellular labelling in 
either the hepatocyte or the endothelial cell. Mag 
x 49,500
SD - space of Disse EC - endothelial cell
H - hepatocyte

Fig 9.13
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
This view shows strong labelling for type III 
collagen which is confined to striated fibres in the 
space of Disse. Mag x 29,2500
H - hepatocyte 
SD - space of Disse
FIG 9.14
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
The collagen fibres adjacent to the hepatocyte are 
strongly labelled for type III collagen, but the 
hepatocyte is completely negative. Mag x 49,500
H - hepatocyte
FIG 9.14
FIG 9.15
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
Labelling for type III collagen can be seen on 
collagen bundles in the space of Disse. Individual 
fibres and small aggregates are also labelled within 
the space of Disse. There is no intracellular
labelling in this section.
Mag x 20,500
H - hepatocyte EC - endothelial cell
FSC - Fat-storing cell KC - Kupffer cell
FIG 9.16
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen.
At high magnification the type III collagen is seen 
to be evenly distributed throughout the bundle of 
striated collagen fibres. This is unlike the
pattern found with type I collagen which is 
concentrated at the edges of the bundle. Mag x
135,200
FIG 9.15
FIG 9.17
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
This bundle of striated collagen lying between two 
hepatocytes is heavily labelled for type III 
collagen. In comparison, there is no intracellular 
or pericellular labelling of the hepatocytes. Mag 
x 16,875 
H - hepatocyte
Figure 9.17
FIG 9.18
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen. 
Fat-storing cells were often surrounded by bundles 
of collagen. In contrast to hepatocytes, the fat- 
storing cells were frequently labelled for type III 
collagen in a pericellular pattern in many 
instances. There was no intracellular labelling 
found in these areas.
Mag x 7,150
FSC - Fat-storing cell EC - endothelial cell
FIG 9.19
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type III collagen.
A higher magnification of Figure 9.18 demonstrates 
the type III collagen adjacent to the fat-storing 
cell.
Mag x 14,275
FSC - Fat-storing cell
FIG 9.19
Type IV collagen Labelling for this component could be 
identified around blood vessels and bile ducts. Although 
a conventional basement membrane could not be identified by 
electron microscopy, type IV collagen was found within the 
space of Disse, often near bundles of striated collagen but 
not on the bundles or within hepatocytes (Fig 9.20), fat- 
storing cells (Fig 9.21) or Kupffer cells (Figs 9.22 and 
9.23). Fig 9.24 shows a low power view of a hepatic
sinusoid, and Fig 9.25 illustrates the labelling for type 
IV collagen within the space of Disse. It was found below 
the endothelial cells (Fig 9.26), and surrounding the fat- 
storing cells (Fig 9.27) but no intracellular labelling was 
seen. The subendothelial labelling was present along the 
space of Disse (Figs 9.28a and 9.28b). When this is
examined at a higher magnification, the labelling is 
confined to a number of small linear areas which correspond 
to amorphous material within the space of Disse (Fig 9.29).
Type V collagen. Immunolabelling with anti-type V
collagen was only effective in Bouins fixed tissue at light 
level microscopy, and gave no positive results when used 
for ultrastructural studies, irrespective of the use of the 
pre-treatments previously discussed.
Type VI collagen When this collagen was immunolocated at 
the ultrastructural level, labelling for type VI collagen 
was present within the space of Disse and portal tract 
stroma. It differed from the other collagen types in
several ways. The gold particles were frequently found
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FIG 9.20
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen.
This shows type IV collagen within the space of
Disse. Labelling is present but striated collagen
bundles are not labelled and there is no
intracellular labelling.
Mag x 26,500 
C - collagen SD - space of Disse 
H - hepatocyte
FIG 9.21
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen. 
Type IV collagen can be identified within the space 
of Disse in areas containing amorphous material 
rather than striated collagen bundles. The fat- 
storing cell is not labelled intracellularly . Mag 
x 31,500
FSC - Fat-storing cell 
H - hepatocyte
% 
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Fig 9.21
FIG 9.22
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen. 
Here the type IV collagen is deposited along the 
space of Disse. The gold particles are regularly 
distributed. Mag x 22,050 
SD - space of Disse 
KC - Kupffer cell 
H - hepatocyte
FIG 9.23
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen. 
When the Kupffer cells were examined for type IV 
collagen there was no intracellular labelling, 
although there was extracellular labelling
immediately adjacent. Mag x 16,750 
KC - Kupffer cell

FIG 9.24
Ultracryosection of normal human liver.
This low power shows the hepatic sinusoid lined with 
endothelial cells, 
hepatocytes can also be 
enlarged in Fig 9.26.
S - sinusoid 
Disse
EC - endothelial cell 
cell
H - hepatocyte
FIG 9.25
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen.
The space of Disse contains linear deposits of type 
IV collagen, but no conventional basement membrane 
is visible. Mag x 9,675
FSC - Fat-storing cell H - hepatocyte
Fat-storing cells and 
seen. The area marked * is 
Mag x 6,300
SD - space of 
FSC - Fat-storing
rFIG 9.24
FIG 9.25
FIG 9.26
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen. 
Labelling for type IV collagen is seen here below 
the endothelial cells within the space of Disse. 
It is also present around collagen bundles and fat- 
storing cells. Mag x 15,500
FSC - Fat-storing cell C - collagen
EC - endothelial cell H - hepatocyte
FIG 9.27
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen 
At high power, the type IV collagen can be seen 
immediately adjacent to a fat-storing cell. No 
intracellular labelling is visible. Mag x 28,500 
FSC - Fat-storing cell C -
collagen
FIG 9.26
FIG 9.27
FIG 9.28a
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen.
In this view of type IV collagen within the 
sinusoid, the endothelial cell can be seen lining 
the hepatic sinusoid. Mag x 26,500 
EC - endothelial cell S - sinusoid
FIG 9.28b
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen.
At higher power, the type IV collagen is seen 
deposited in a regular pattern along the space of 
Disse. Mag x30,450
EC - endothelial cell H - hepatocyte
SD - space of Disse
FIG 9.28a
FIG 9.28b
FIG 9.29
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type IV collagen 
When Figure 9.28b is examined at a higher 
magnification, it can be seen that the labelling for 
type IV collagen is present on amorphous material 
within the space of Disse, but this does not have 
the same appearance as a conventional basement 
membrane. Mag x 4 9,500
EC - endothelial cell H - hepatocyte
FIG 9.30
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for type VI collagen 
The labelling for type VI collagen is present around 
the edges of striated collagen bundles and also 
between the individual striated fibres. It is less 
commonly found on the individual fibres. Mag x
47,250
FSC - Fat-storing cell
FSC
Figure 9.30
immediately adjacent to the bundles of striated collagen 
fibres, but were rarely found on the bundles. Instead, 
they could be found in between and surrounding the fibres
(Fig 9.30). The type VI collagen structures which were
labelled were rarely visible, but were occasional seen as 
fine unstriated filaments or amorphous material weaving
between the collagen bundles. Intracellular labelling was 
restricted to the endoplasmic reticulum of occasional fat- 
storing cells and was of low intensity.
9.9 Fibronectin
This was immunolocated within the space of Disse 
(often adjacent to fat-storing cells (Fig 9.31), and in 
portal tracts. It was also found within several cell 
types. In some hepatocytes, it was localised to the
endoplasmic reticulum and lysosomes (Fig 9.32). It was 
also seen in lysosomes within Kupffer cells. In many
cases it was closely associated with bundles of striated 
collagen (Fig 9.33)
9.10 Vitronectin
When anti-vitronectin antibody was used for 
ultrastruetural studies, the degree of labelling was so low 
that it could not be distinguished from the background 
labelling. None of the pre-treatments previously
described improved the degree of labelling.
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FIG 9.31
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for fibronectin.
This shows fibronectin within the space of Disse. 
The labelling is present immediately adjacent to 
fat-storing cells, but not intracellularly. Mag
x 25,875
FSC - Fat-storing cell
FIG 9.32
Ultracryosection of normal human liver.
Immunogold labelling ( 5nm) for fibronectin.
This shows fibronectin within the endoplasmic 
reticulum of a hepatocyte. The mitochondria of the 
cell are all negative. Mag x 49,500
M - mitochondria
FIG 9.31
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FIG 9.32
FIG 9.33
Ultracryosection of normal human liver.
Immunogold labelling (lOnm) for fibronectin. 
Fibronectin is present throughout the space of 
Disse, but the labelling is strongest when 
associated with the bundles of striated collagen 
fibres. Mag x 18,000 
C - collagen 
EC - endothelial cell
9.11 Laminin
The antibodies for laminin were the most fixation 
sensitive in this study. They were tested in a range of 
fixatives (see table 10.1) and the only positive results 
obtained were with tissue fixed in Bouins fixative or in 2% 
paraformaldehyde (+ 0.1 glutaraldehyde) . The only tissue 
samples large enough to be divided into a number of samples 
and fixed in a range of fixatives were those obtained from 
cadaveric renal transplant donors. Bouins fixed tissue was 
unsuitable for ultrastructural studies. The laminin 120kD 
antibody did give positive results when used for light 
microscopic immunolabelling studies on the paraformaldehyde 
fixed material, but the labelling obtained with 
ultrastructural techniques was far weaker. There was
occasional labelling around the blood vessels and bile 
ducts, with faint discontinuous deposits in the space of 
Disse. This staining pattern was weak and in many cases 
there was no appreciable labelling.
9.12 Ultrastructural immunolabelling of normal liver.
Using the antibodies available for this study it was 
possible to immunolocalise collagen types I, III, IV and 
VI, and fibronectin with both light and ultrastructural 
microscopy. Antibodies for type V collagen, vitronectin 
and laminin were only suitable for light microscopy 
studies, and the antibody for undulin was unsuitable for 
all of the material used in this study.
The area where the majority of immunolabelling was 
found was within the space of Disse. This was true of all
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the antibodies used. It was decided to concentrate on a 
smaller number of antibodies for the study of diseased 
liver tissue. These would be used for light microscopy 
and ultrastructural studies. The antibodies chosen were 
to collagen types I, III, IV and VI, and to fibronectin. 
Type V collagen was examined with light microscopy alone.
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CHAPTER 10. EXTRACELLULAR MATRIX COMPONENTS IN DISEASED 
LIVER.
10.1 Immunocytochemistry at light microscopy level
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10.1. Immunocytochemistry at light microscope level.
The immunocytochemical studies on diseased liver were 
limited by two factors. The first problem was the
availability and size of material. The vast majority of 
biopsies used in this study were needle biopsies of liver. 
These are small cores of tissue and a substantial part of 
the material was required for diagnostic purposes. The 
second problem which arose from the use of archival 
material was the adverse effects of fixation used for 
routine biopsies on immunoreactivity. Buffered formalin
or formol corrosive were the fixatives used routinely, and 
these were unsuitable for a number of antibodies including 
those against type IV collagen, laminin, type V collagen 
and vitronectin. For these reasons, the majority of the 
study of diseased liver was carried out with material which 
had been specifically prepared for electron microscopy. 
The exception to this was the study of type VI collagen. 
The localisation of this collagen within human liver was 
unknown, in both normal and diseased tissue. As anti-type 
VI collagen antibody was effective on formalin-fixed 
material, it was examined at both light microsopic and 
ultrastructural levels. The antibodies for types I and 
III collagen were also suitable for use with formalin-fixed 
material although the distribution of these collagens has 
already been documented by other groups using light
microscopy (see chapter 6).
The most striking overall observation was the 
difference between acute and chronic liver diseases. 
There was no alteration of the distribution or intensity of
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Frozen Bouins 2% paraform 2% paraform/
0.1% glutaraldehyde
Type IV
(7s) +++ +++ ++ ++
(NCI) + + + -
pro IV ++ ++ + “
Laminin
PI ++ ++ - -
12 OkD +++ +++ ++ +
60kD ++ + - -
Table 10.1 Effects of fixation on immunolabelling.
For all of the above antibodies, neither 2% glutaraldehyde or 
formol corrosive gave positive labelling
labelling for extracellular matrix proteins in acute 
hepatitis. In contrast , several alterations were found 
in chronic liver diseases. As there were only a small 
number of biopsies available for each of the different 
forms of liver disease, the alterations to the 
extracellular matrix described here may not be found in all 
cases and must be regarded as an indication of the changes 
in the hepatic extracellular matrix during the disease 
process.
10.2 Distribution of collagen
Types I and III collagen. In pre-cirrhotic primary
biliary cirrhosis the pattern of collagen distribution was 
altered in the periportal zones. Elsewhere the pattern of 
distribution was similar to that in normal liver (Figs 10.1 
and 10.2). Types I and III collagen were immunolocalised 
to fibrotic septa (Fig 10.5). In one of the sclerosing 
cholangitis cases, increased labelling for type I and III 
collagen was confined to the areas of damage around the 
bile ducts (Figs 10.3 and 10.4). In cases of acute liver 
disease such as Hepatitis A, there was no alteration in the 
pattern of collagen types I and III (Fig 10.6).
Type VI collagen. When biopsies from patients with
primary biliary cirrhosis were examined, the pattern of 
type VI collagen expression altered as the disease 
progressed. There were no alterations in stage 1
biopsies, but in stages 2 and 3 intense staining was seen 
around proliferating bile ductules, which were located
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within developing fibrotic septa (Fig 10.7). In stage 4 
PBC with established cirrhosis, there was strong 
immunoreactivity within the fibrotic septa (Fig 10.10). 
Although there were no appreciable alterations in 
immunoreactivity along sinusoidal walls at any stage, the 
level of staining was always higher in zones 2 and 3 than 
in zone 1. This finding was unique to type VI collagen.
In other chronic liver diseases, the pattern of type 
VI collagen distribution was also altered. In alcoholic 
cirrhosis and in fibrosis there is strong staining within 
the septa (Fig 10.8 and Fig 10.11). In acute liver
disease such as Hepatitis A, there was an increase in type 
VI collagen within the areas of inflammation (Fig 10.12).
Type V collagen. The distribution of type V collagen was 
similar to that of types I and III collagen. It was found 
within areas of fibrosis (Fig 10.13) but there was no 
increase in acute liver disease (Fig 10.14). Although 
type V collagen was always increased within areas of 
fibrosis, the remainder of the liver did not show any signs 
of increased type V collagen deposition (Figs 10.15 and 
10.16)
10.3 Fibronectin. The intensity of labelling for
fibronectin was increased in chronic liver disease, but the 
pattern of distribution was the same as in normal liver and 
it was not associated with any fibrotic septa present.
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FIG 10.1
Distribution of type I collagen in primary biliary 
cirrhosis. (peroxidase-antiperoxidase labelling). 
In this example of primary biliary cirrhosis, the 
increased labelling for type I collagen can be seen 
in the periportal zone (zone 1). The rest of the 
parenchyma appears to have a normal pattern of type 
I collagen distribution.
FIG 10.2
Distribution of type III collagen in primary biliary 
cirrhosis. (peroxidase-antiperoxidase labelling). 
The deposition of type III collagen in this example 
of stage 3 primary biliary cirrhosis is the same as 
type I collagen.
FIG 10.1
FIG 10.2
FIG 10.3
Distribution of type I collagen in primary
sclerosing cholangitis. (peroxidase-antiperoxidase
labelling).
In this case of primary sclerosing cholangitis, the 
labelling is seen surrounding the proliferating bile 
ductular structures. Increased labelling for type 
I collagen is also seen in the space of Disse.
FIG 10.4
Distribution of type III collagen in primary 
sclerosing cholangitis. (peroxidase-antiperoxidase 
labelling).
This low power illustration of type III collagen 
demonstrates the localised areas of increased 
collagen deposition. The labelling is prominent 
around the portal tract (PT) which has accompanying 
portal/periportal fibrosis. It is also seen in 
this case around an interlobular hepatic vein branch 
(HV)
FIG 10.3
FIG 10.4
L
FIG 10.5
Distribution of type I collagen in primary biliary 
cirrhosis. (peroxidase-antiperoxidase labelling). 
This case of biliary cirrhosis is illustrative of a 
chronic fibrotic liver disease. Type I collagen is
present in increased amounts in the areas of 
fibrotic tissue deposition, and these are starting 
to join together and form fibrotic septa.
FIG 10.6
Distribution of type I collagen in hepatitis A. 
(peroxidase-antiperoxidase labelling).
In contrast to Fig 10.5, this form of acute liver 
disease (Hepatitis A) shows little sign of increased 
type I collagen deposition and there are no fibrotic 
areas present.
; L
TV'" #»;
f Ml K  i 1 -
\  . * (il
MEKi
, - ■ ... ,
'J .•' i
■-* TILVEf
tjrSmAftik*
FIG 10.5
I]
i>. #• «•■■
‘ j. 4« 4* J*>■ *"■ 4,7; #. . >• i  i “ , ♦
, * '* * - ■•*< V | *’■*
r '.
5'.; > ;•
V .
• if
FIG 10.6
FIG 10.7
Distribution of type VI collagen in primary biliary 
cirrhosis. (peroxidase-antiperoxidase labelling). 
In this case of primary biliary cirrhosis, type VI 
collagen can be seen around proliferating bile 
ductules.
FIG 10.8
Distribution of type VI collagen in alcoholic 
cirrhosis. (peroxidase-antiperoxidase labelling). 
There is strong staining for type VI collagen in the 
fibrotic septa found in a case of alcoholic 
cirrhosis. The level of staining in the space of 
Disse within adjacent cirrhotic nodules is weaker.

FIG 10.9
Distribution of type VI collagen in sclerosing 
cholangitis. (peroxidase-antiperoxidase labelling). 
In sclerosing cholangitis the areas of increased 
type VI deposition are the same as for types I and 
III collagen, i.e. around proliferating bile 
ductules and portal tracts.
FIG 10.10
Distribution of type VI collagen in primary biliary 
cirrhosis. (peroxidase-antiperoxidase labelling). 
Labelling for type VI collagen is present in greatly 
increased amounts throughout the areas of fibrosis 
in this case of primary biliary cirrhosis, and is 
not limited to areas immediately adjacent to the 
proliferating ductules.
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FIG 10.11
Distribution of type VI collagen in fibrotic liver,
(peroxidase-antiperoxidase labelling).
This low power view of type VI collagen in fibrotic 
liver illustrates the similarity of type VI 
distribution to that of the other fibrillar 
collagens.
FIG 10.12
Distribution of type VI collagen in hepatitis A. 
(peroxidase-antiperoxidase labelling).
In acute liver disease such as hepatitis A, there is 
no increase in the amount of type VI collagen.
FIG 10.11
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FIG 10.13
Distribution of type V collagen in primary
sclerosing cholangitis. (peroxidase-antiperoxidase
labelling).
Labelling of type V collagen can be seen within a 
fibrotic portal tract.
PT - portal tract BD - bile ductules
FIG 10.14
Distribution of type V collagen in hepatitis A. 
(peroxidase-antiperoxidase labelling).
In acute liver disease (Hepatitis A) there is no 
increase in type V collagen deposition.

FIG 10.15
Distribution of type V collagen in alcoholic 
cirrhosis. (peroxidase-antiperoxidase labelling). 
The fibrotic septa found in alcoholic cirrhosis 
contain type V collagen in a similar distribution to 
that of other fibrillar collagens.
FIG 10.16
Distribution of type V collagen in alcoholic 
cirrhosis. (peroxidase-antiperoxidase labelling). 
There is no increased labelling of type V collagen 
in the space of Disse within cirrhotic nodules
FIG 10.15
10.4 Immunocytochemistry at electron microscopy level.
10.5. Collagen
Type I collagen. In some conditions (nodular regenerative 
hyperplasia and intrahepatic cholestasis), there were no 
detectable alterations in either the distribution or 
intensity of immunolabelling. In comparison material from 
patients with primary biliary cirrhosis and primary 
sclerosing cholangitis had increased labelling for both 
types I and III in the portal tracts and space of Disse 
(Figs 10.17, 10.18). Patients with alcoholic hepatitis
also had increased labelling for type I and III in the 
space of Disse. This increased labelling was found in all 
of the chronic diseases studied, but not in acute liver 
disease. When fibrotic septa were present, in chronic
liver diseases such as primary biliary cirrhosis or 
hepatitis B, they also contained type I collagen.
All the labelling in these sections was extracellular. 
Tha antibodies which had been used were raised against the 
fully processed form of the collagen, which is found 
extracellularly. Within collagen-producing cells, much of 
the collagen is present in the partially processed or pro­
peptide form. In order to determine the cells responsible 
for the production of type I collagen, antibodies to both 
the processed type I collagen and to the type I collagen 
pro-peptide were used. Only the procollagen antibody
appeared to be effective, with positive labelling within 
some fat-storing cells (Fig 10.19, 10.20). All other
cell types were negative. As discussed in 9.7, the
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FIG 10.17
Ultracryosection of hepatitic liver.
Immunogold labelling (lOnm) for type I collagen 
These heavily labelled type I collagen fibres are 
immediately adjacent to a fat-storing cell.
Mag x 96,750
FSC - Fat-storing cells
FIG 10.18
Ultracryosection of a liver with primary sclerosing 
cholangitis.
Immunogold labelling (lOnm) for type I collagen 
Labelling for type I collagen can be seen
surrounding the entire fat-storing cell, in both 
bundles and individual fibrils.
Mag x 16,000
FSC - Fat-storing cells
rFIG 10.17
FIG 10.18
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FIG 10.19
Ultracryosection of hepatitic liver 
Immunogold labelling (lOnm) for type I collagen 
This fat-storing cell is surrounded with collagen 
bundles containing immunoreactive type I collagen. 
The endoplasmic reticulum is swollen, indicating 
active protein synthesis.
Mag x 15,500
FSC - Fat-storing cells
FIG 10.20
Ultracryosection of hepatitic liver 
Immunogold labelling (lOnm) for type I collagen 
At higher magnification, the dilated endoplasmic 
reticulum can be seen to contain immunoreactive type 
I procollagen. Mag x 40,500
FIG 10.19
FIG 10.20
FIG 10.22
FIG 10.21
Ultracryosection of cholestatic liver 
Immunogold labelling (lOnm) for type III collagen 
In this cholestatic liver, there is heavily labelled 
type III collageTi deposited in the space of Disse. 
Mag x 29,900
FIG 10.22
Ultracryosection of a liver with alcoholic 
cirrhosis.
Immunogold labelling (lOnm) for type III collagen 
Fat-storing cells in the space of Disse are 
surrounded by large amounts of striated collagen.
Mag x 4 7,250
FSC - Fat-storing cell
FIG 10.23
Ultracryosection of cirrhotic liver.
Immunogold labelling (lOnm) for type III collagen 
This biopsy was immunolabelled for type III 
collagen. The hepatocyte is not labelled
intracellularly , although type III collagen can be 
seen immediately adjacent to the cell. The
collagen bundles occupy most of the space of Disse, 
with labelled individual fibres also present.
Mag x 17,500
SD - space of Disse H - hepatocyte
FIG 10.24
Ultracryosection of a liver with alcoholic liver 
disease
Immunogold labelling (lOnm) for type III collagen 
In some cases of alcoholic liver disease, type III 
collagen fibres may encase the hepatocytes as seen 
here. These bundles form a meshwork which
surrounds the cell. The hepatocytes are negative. 
Mag x 15,000 
H - hepatocyte
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FIG 10.24
staining was marginally enhanced if the sections were pre­
treated with hyaluronidase to remove the glycosaminoglycan 
component of the extracellular matrix, but the level of 
intensity remained low.
Type III collagen. The pattern of distribution was 
essentially the same as for type I collagen with increased 
amounts of collagen in chronic liver diseases (Fig 10.21, 
10.22). In most fibrotic conditions, increased amounts of 
collagen were found in the space of Disse adjacent to the 
sinusoidal aspect of the hepatocyte (Fig 10.23). In a 
number of cases of alcoholic hepatitis,the extent of 
collagen deposition was increased and striated fibres could 
be seen around hepatocytes. Fig 10.24 shows an example of 
this pattern. The labelled collagen extends from the
space of Disse around the perimeter of the hepatocyte.
Type IV collagen. There were several major alterations in 
the distribution of type IV collagen in diseased liver. 
In primary biliary cirrhosis, the areas around the bile 
ducts were far more strongly labelled than in normal liver 
(Fig 10.25). This labelling was adjacent to, but separate 
from, the striated fibres also present. There was also 
increased type IV collagen in the sub-endothelial region of 
the space of Disse (Fig 10.26). The increase in type IV 
collagen was often adjacent to fat storing cells (Fig 
10.27), but there was no intracellular labelling in any of 
these sections.
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FIG 10.25
Ultracryosection of a liver with primary biliary 
cirrhosis
Immunogold labelling (lOnm) for type IV collagen 
The labelling for type IV collagen is more intense 
than that present in normal liver.
Mag x 22,050
BD - bile duct epithelial cell
FIG 10.26
Ultracryosection of a liver with primary biliary 
cirrhosis.
Immunogold labelling (lOnm) for type IV collagen 
Increased labelling for type IV collagen is also 
found in the space of Disse, in a sub-endothelial 
distribution.
Mag x 17,550
C - collagen bundles EC - sinusoidal endothelial
cell
- £
FIG 10.26
FIG 10.27
Ultracryosection of a liver with primary biliary 
cirrhosis.
Immunogold labelling (lOnm) for type IV collagen 
This fat-storing cell is surrounded by 
immunoreactive type IV collagen. No intracellular 
labelling is present.
Mag x 26,500
FSC - Fat-storing cells
FIG 10.28
Ultracryosection of a liver with primary sclerosing 
cholangitis.
Immunogold labelling (lOnm) for type IV collagen 
Type IV collagen has been deposited along the 
borders of the space of Disse, in a regular pattern. 
Mag x 44,000
SD - space of Disse H - hepatocyte
FIG 10.28
FIG 10.29
Ultracryosection of a liver with primary sclerosing 
cholangitis
Immunogold labelling (lOnm) for type IV collagen 
Type IV collagen can be seen around the edges of the 
hepatocytes. The striated collagen bundle are
negative.
Mag x 22,050
C - collagen bundles H - hepatocyte
FIG 10.30
Ultracryosection of a liver with primary sclerosing 
cholangitis.
Immunogold labelling (lOnm) for type IV collagen 
This higher power illustrates labelling of type IV 
collagen around the hepatocytes. The labelling is 
localised to amorphous material.
Mag x 30,050 
H - hepatocyte
FIG 10.29
FIG 10.30
FIG 10.31
Ultracryosection of a liver with primary sclerosing 
cholangitis.
Immunogold labelling (lOnm) for type IV collagen 
The striated collagen in the space of Disse is 
negative for type IV collagen. The labelling is 
confined to the amorphous material surrounding the 
hepatocyte.
Mag x 49,500 
C - collagen
The pattern of type IV collagen deposition in 
sclerosing cholangitis appeared to become more organised 
than in normal liver, where it is localised to discrete, 
amorphous clumps. Labelling forms a continous line along 
the space of Disse, with a few gaps (Fig 10.28). As well
as an increase in the amount of type IV collagen in the 
space of Disse, it is distributed around the hepatocytes. 
A continuous undulating line which contains type IV 
collagen, surrounds individual cells (Figs 10.29, 10.30 and 
10.31) .
Type VI collagen. The intensity of labelling for type VI 
collagen was increased in a number of fibrotic conditions. 
It was also increased in one case of nodular regenerative 
hyperplasia, within the space of Disse and associated with 
amorphous material (Fig 10.39).
In cirrhotic livers, the type VI collagen was 
frequently seen adjacent to striated collagen bundles 
(Figs 10.32, 10.33). Intracellular labelling was also
seen with labelling found in fat-storing cells (Fig 10.34), 
often adjacent to the collagen bundles. In some biopsies 
it could be clearly seen that the type VI collagen was 
concentrated at the edges of the striated collagen bundles 
within the space of Disse (Fig 10.35). Due to the size of 
the tissue pieces used for electron microscopy, it often 
was not possible to identify the zone present and it was 
therefore not possible to compare the intensity of type VI 
labelling within the acini at the ultrastructural level.
114
FIG 10.32
Ultracryosection of cirrhotic liver 
Immunogold labelling (lOnm) for type VI collagen 
Type VI collagen within the space of Disse is 
frequently associated with striated fibres, and the 
majority of the gold particles are located on and 
around striated collagen fibres, 
mag x 4 9,500
SD - space of Disse KC - Kupffer cell
FIG 10.33
Ultracryosection of cirrhotic liver 
Immunogold labelling (lOnm) for type VI collagen 
When fig 10.32 is examined at higher magnification, 
it can be seen that the type VI collagen is located 
around (a), and between (b), the striated fibres, 
mag x 9 6,750 
C - collagen
FIG 10.32
urn
FIG 10.33
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FIG 10.34
Ultracryosection of cirrhotic liver 
Immunogold labelling (lOnm) for type VI collagen 
Labelling for type VI collagen is seen on the 
endoplasmic reticulum of this fat-storing cell, 
suggesting synthesis of the type VI collagen.
Mag x 44,000
ER - endoplasmic reticulum
FIG 10.35
Ultracryosection of a liver with primary biliary 
cirrhosis.
Immunogold labelling (lOnm) for type VI collagen 
The type VI collagen in the space of Disse is 
concentrated around the edges of the striated 
collagen bundle, with small amounts present within 
the bundle itself, 
mag x 4 9,500
C - collagen bundle H - hepatocyte

FIG 10.36
Ultracryosection of a liver with chronic active 
hepatitis
Immunogold labelling (lOnm) for type VI collagen 
The type VI collagen in this section is evenly 
distributed throughout the striated fibres. The 
labelling is far more intense than in normal liver, 
mag x 60,000
EC - endothelial cell H - hepatocyte
Figure 10.36
FIG 10.37
Ultracryosection of a liver with chronic active 
hepatitis
Immunogold labelling (lOnm) for type VI collagen 
There is heavy labelling for type VI collagen in 
this section, but the distribution is uneven and 
concentrated on the outer edges of the bundle, 
mag x 40,500
C - collagen fibres EC - endothelial cell
FIG 10.38
Ultracryosection of a liver with chronic active 
hepatitis
Immunogold labelling (lOnm) for type VI collagen 
In this section, labelling for type VI collagen can 
be seen next to the striated fibres and also within 
an adjacent fat-storing cell, 
mag x 55,000
EC - endothelial cell SD - space of Disse
FSC - Fat-storing cells
FIG 10.37
FIG 10.38
L
FIG 10.39
Ultracryosection of a liver with nodular 
regenerative hyperplasia
Immunogold labelling (lOnm) for type VI collagen 
The space of Disse is heavily labelled, both on 
amorphous material and adjacent to striated fibres. 
There is no intracellular labelling, 
mag x 34,875
EC - endothelial cell SD - space of Disse
H - hepatocyte

FIG 10.40
Ultracryosection of a liver with nodular 
regenerative hyperplasia
Immunogold labelling (lOnm) for type VI collagen 
This area of disordered collagen fibres within the 
space of Disse is heavily labelled for type VI 
collagen. 
mag x 2 9,250
SD - space of Disse H - hepatocyte
In cases of chronic active hepatitis the type VI 
collagen was strongly labelled within the space of Disse 
(Figs 10.36 and 10.37). The fat-storing cells within the 
space of Disse were occasionally labelled intracellularly 
(Fig 10.38) .
Some of the strongest labelling was found in the case 
of nodular regenerative hyperplasia. This was in the
space of Disse, on amorphous material as well as near 
striated collagen (Fig 10.39). An unusual finding in this 
condition was the large amount of collagen which was 
disordered rather than in discrete bundles (Fig 10.40). 
This was rarely seen in other conditions. These disordered 
areas of collagen were very strongly labelled.
10.6 Fibronectin.
There was no alteration in the distribution of fibronectin, 
although the strength of labelling was increased. It was 
often found intracellularly in hepatocytes and fat-storing 
cells, and in lysosomes of Kupffer cells. It was found in 
association with most collagen bundles and
throughout the space of Disse,
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11.1. The development of ultracryomicrotomy.
When immunocytochemical studies were first carried out 
at the ultrastructural level, most groups used resin- 
embedded material. The use of resin as an embedding
material often rendered the tissue unsuitable or even 
unuseable for some immunocytochemical studies.
One possible solution to this problem was to 
immunolabel the tissue prior to processing and resin 
embedding (pre-embedding). Unfortunately this was not a 
suitable method for this study. In order to examine the 
tissue with a range of antibodies, a number of blocks would 
each have to be immunolabelled with a single antigen before 
embedding. Using post-embedding techniques, a number of 
individual sections from the same block can be 
immunolabelled with different antibodies.
A number of post-embedding techniques have been 
developed. The use of ultracryomicroscopy overcame many 
of the deficiencies discussed above. Many different
fixation regimes are suitable. After fixation, the only 
substance which the tissue is exposed to during embedding 
is an aqueous solution of sucrose, and if the freezing 
proceedure has been carried out correctly, there is no ice 
crystal damage. Initially this method seemed to remove 
many of the problems associated with ultrastructural
immunocytochemistry.
There are however, a number of novel drawbacks with 
this method. The tissue must be stored in liquid nitrogen 
cifter sucrose treatment, and the maximum storage time has 
not been determined. In comparison, resin embedded blocks
can be stored indefinitely. It is far more difficult to 
identify the area of the block face of interest and trim it 
for ultrasectioning in a frozen piece of tissue than in a 
resin embedded block, and if it is necessary for one 
particular aspect of the tissue to be studied, e.g portal 
tracts in liver, this may result in the waste of 
significant amounts of tissue and make it necessary to 
examine a number of individual blocks in order to obtain 
suitable material.
In this study, one of the first difficulties 
encountered in the use of ultracryomicrotomy sections was 
the identification of the different cell types and of the 
intracellular features. Some of the cells, such as
Kupffer cells and fat-storing cells, did not differ much in 
appearance from those in resin embedded tissue, but the 
biggest difference was found in the appearance of 
hepatocytes. This however, did not interfere with their 
identification. Within the hepatocytes the best preserved 
structures were all membraneous, whereas the water soluble 
structures, such as glycogen, were poorly preserved (Burt 
et al, 1990). This gave the initial impression of a 
number of holes within the tissue. Although some of these 
"holes" were due to freezing damage (formation of ice 
crystals), the majority are probably due to the loss of the 
water-soluble glycogen particles. This is supported by 
the fact that the non-parenchymal cells which do not 
contain glycogen showed far fewer signs of damage.
Thi s alteration in appearance was an important aspect 
to consider when using ultracryomicrotomy. If the
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morphological appearance is critical then it may be 
advisable to consider other, more conventional, 
ultrastructural methods which allow easy identification of 
cell structure. In this study the immunocytochemical
aspects were as least as important as the morphological 
ones, and this resulted in the use of ultracryomicrotomy.
11.2. The use of immunogold rather than immunoperoxidase 
labelling.
There are a number of different labelling systems 
which can be used for immunocytochemistry, but at the 
ultrastructural level the choice is more limited due to 
several factors. The two systems most commonly used are 
immunoperoxidase and immunogold. The advantage of the
immunoperoxidase method is that a number of commercial 
antibodies are available ready conjugated to peroxidase 
(giving a one-step method), and an indirect method can also 
be used, especially if amplification of the signal is 
required. In this study it would have been necessary to 
use the indirect method, as the antibodies were only 
available in an unconjugated form. Although it was
technically possible to conjugate our own antibodies, this 
could have introduced labelling variables (each antibody 
would bind differently to the gold particles, and there 
would also be labelling variation between batches).
The major drawback of the peroxidase method was that 
although the label was electron dense, it has a rather 
fuzzy appearance and can be difficult to identify in some 
tissues when they have been counterstained. In liver, it
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may be confused with glycogen rosettes, which have a 
similar ultrastructural appearance. Another potential
problem was that the size of the peroxidase particles 
cannot be altered, and this precludes the use of double 
labelling. As double labelling may be necessary to
distinguish two different antigens which have similar but 
not identical distributions, the use of peroxidase 
labelling can limit experimental design.
The choice of an immunogold labelling method solved a 
number of these problems. It is unusual to use specific 
antibodies directly conjugated to gold particles. The 
gold conjugates which are used as the second layer are 
commercially available in a range of sizes from <lnm to 
40nm in diameter. The most common sizes used are 5, 10
and 15nm in diameter, which are all commercially available. 
Anything larger than this has reduced labelling efficiency 
due to poor penetration into the tissue (Lackie, 1975). 
Secondary antibodies conjugated to gold particles which are 
smaller than 5nm are very sensitive and will penetrate 
tissue easily, but require silver enhancement to be 
identified. The silver enhancement technique utilises the 
ability of the gold particles to act as a nucleating agent 
with a silver suspension. This means that silver grains 
are deposited on the outside of the gold particles, thus 
giving a larger and more easily visualised label. If
double labelling is necessary, the immunogold system is 
suitable as two different particle sizes (usually 5 and 
15nm) can be used to label the two antigens (Beesley,
1989) .
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Ultracryomicrotomy was chosen for the electron 
microscopy part of this study in an attempt to minimise the 
damage to the tissue antigens, and the immunogold labelling 
method was believed to give the clearest results. Once
this decision was made, the basic techniques had to be 
adapted and developed to suit the tissue and the antibodies 
which were to be used. There were a number of factors 
which had to be determined. For optimum preservation of 
tissue morphology and antigenicity, a range of freezing 
conditions and different counterstaining regimes were 
examined. As well as this, each antibody required a
different combination of enzymatic pretreatments to remove 
other constituents of the extracellular matrix, blocking 
agents to prevent non-specific binding and antibody 
dilutions. These requirements varied between light
microscopy and ultrastructural microscopy and have already 
been described in Chapter 9.
11.3. The effect of fixation.
One of the most important factors which determined the 
direction of this study was the effect of fixation on 
immunolabelling. While the tissue for the ultrastructural 
studies was collected and fixed specifically for this , the
small size of tissue biopsies available meant that it was
not possible to use a wide range of fixatives. As a
result, the ultrastructural studies were limited to the 
antibodies which worked with paraformaldehyde or 
paraformaldehyde/glutaraldehyde-fixed material.
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With the material to be used for light microscopy, a 
number of the antibodies available were found to be 
ineffective on tissue which had been fixed in formol 
corrosive, and this meant that it was not feasible to use 
archival material for antibodies such as anti-laminin and 
anti-type IV collagen. The use of these antibodies was 
restricted to tissue which was collected during this study 
and processed in a number of different fixatives. 
Archival material was used for the antibodies which were 
less "fixation-sensitive".
11.4. The problems of intracellular labelling.
When the different parameters for sectioning and 
immunolabelling had been optimised, the extracellular 
matrix of human liver was examined using a range of 
antibodies. It soon became obvious that although a number 
of the the antibodies were effective at labelling the 
extracellular spaces and pericellular areas, there was 
little or no labelling found intracellularly. Other
groups have failed to demonstrate intracellular labelling 
(Grimaud et al, 1980, Martinez-Hernandez, 1984). Previous 
studies by other groups working on animal tissues (Geerts 
et al, 1986; Clement et al, 1984; Clement et al, 1985) gave 
contradictory evidence of intracellular labelling, with 
some of the positive labelling found in vesicles rather 
than in endoplasmic reticulum. Although these were
described as Golgi vesicles, it was possible that they 
could be endocytotic vesicles. This meant that the
labelling could indicate the uptake of extracellular matrix
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proteins rather than their synthesis. Smedsrod et al
(1986) have already demonstrated the hepatic endothelial 
cells are capable of endocytosing extracellular matrix 
components such as type I collagen. The amount of
intracellular labelling in these studies was low in 
comparison to the extracellular labelling seen. This
decrease may be due to masking of the antigens present 
within the cell. All reports of intracellular labelling 
were obtained with the ultrastructural immunoperoxidase 
method (Clement 1986, 1988)
Another possible explanation is that the collagen 
present within the cells is in the form of precursor 
collagen and the antibodies used are raised against the 
fully processed collagen. In order to test this theory, 
antibodies were used which had been raised against the 
propeptide portion of collagen molecules. These label 
extracellular collagen fibres which have not been fully 
processed, but no intracellular labelling was seen (Geerts 
et al, 1986 ) .
The use of ultrathin cryosections meant that a lack of 
intracellular staining was unlikely to be due to an 
inability of the antibodies to penetrate the sections and 
bind to the antigen. This left two other possibilities. 
The first was that the fixation regime used had altered the 
antigen to such an extent that it was unrecognisable, and 
the second possibility was that the antibody was unable to 
access the antigen to which it was raised.
The first theory, that of the fixation effect, may be 
at least partially true in cases where neither
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intracellular or extracellular labelling could be
identified after the use of specific fixation regimes. 
This was the case with some of the antibodies used in this 
study, such as anti-laminin. When tissues which had been 
immunolabelled for laminin were examined using light
microscopy, the presence or absence of staining in extra­
cellular spaces was determined by the fixative used i.e.
all the laminin antibodies gave positive extracellular 
staining in Bouins-fixed material, but negative results in 
formol corrosive-fixed tissue (Table 10.1). Intracellular 
staining was consistently negative, regardless of the 
fixative used. This theory does not explain why the
antibodies which are capable of extracellular labelling in 
optimally fixed tissue are unable to identify any 
intracellular matrix proteins.
All antibodies bind to the antigenic site via a number 
of forces such as hydrophobic, hydrogen bonding, 
electrostatic and Van der Waals forces. As the distance 
between antigen and antibody increases, the bonds are 
weakened. When tissues are chemically fixed, the degree 
of cross-linking within the tissue increases. This can 
lead to weakening of the antibody-antigen bonding and a 
consequent loss of immunolabelling in the tissue.
In order to explain the absence of intracellular 
staining and presence of extracellular cellular staining in 
the same tissue it was necessary to examine the second 
possibility, i.e that the antibody was physically unable to 
recognise the antigen. There were two possible causes of 
this. The first was linked to the complex processing of
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the extracellular matrix proteins. As described in
chapter 4, the synthesis of collagen requires a number of 
processing steps including hydroxylation, glycosylation and 
triple helix formation within the cell, as well as the 
cleavage of extension peptides and assembly of microfibrils 
outside the cell. Much of the collagen within the cell 
(procollagen) was unprocessed and in the form of individual 
a-chains. In contrast to this, the majority of
extracellular matrix antibodies were raised against 
collagen molecules which were isolated and purified in the 
fully processed state. It was possible that the
partially-processed intracellular collagen molecules were 
not recognised by the antibodies which were used in this 
study, although the same antibodies were capable of 
identifying the fully processed collagen molecules which 
were present in the extracellular spaces. This theory is 
unlikely as demonstated by the pro-peptide labelling 
studies (Geerts et al, 1986) discussed above.
Although each of these explanations have been proposed 
as the sole cause for the lack of intracellular labelling, 
it is possible, if not probable, that it is a combination 
of two or three factors which results in the lack of 
intracellular labelling.
11.5. The confirmation of type I and III distribution.
There have been a number of previous descriptions of 
the distribution of type I and III in rat liver and in both 
normal and diseased human liver. The majority of these 
used light microscopy (Hahn et al, 1980, Voss et al, 1980
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Grimaud et al, 1980), with a few resulting from 
ultrastructural studies (Geerts et al, 1986, 1990; Clement
et al, 1985; Martinez-Hernandez, 1984).
The results obtained in this study were generally 
compatible with the findings of these papers, with some 
novel observations in the case of alcoholic hepatitis. 
The distribution of the types I and III collagen were 
similar in normal liver and in diseased liver. There were 
two exceptions to this. The first was the presence of 
types I and III in any fibrotic septa which had developed. 
The second difference was noted in cases of alcoholic 
hepatitis where some of the damaged hepatocytes were 
surrounded by type III collagen.
When the tissue was examined at the ultrastructural 
level, several differences between the two types of 
collagen were apparent. The first was the amount of each 
collagen type, with the majority of fibres positive for 
type III collagen rather than type I. The type III
collagen appeared evenly distributed throughout the 
collagen bundles whereas the type I fibres were often more 
apparent towards the edges of the bundles. Each of the 
antibodies appeared to label a high proportion of the 
collagen fibres, and although double labelling experiments 
were not carried out, this pattern of distribution was 
consistent with previous suggestions that collagen fibres 
may contain both types I and III collagen (Geerts et al,
1990) .
The high proportion of collagen type III propeptide 
retained on fibres was consistent with the suggestion that
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cleavage of the propeptide fraction of type III collagen in 
a fibre is necessary before more type III molecules can 
attach and enlarge the fibre (Lapiere et al, 1977). The 
control mechanism behind this method of size control is not 
yet known. All of these differences in propeptide
distribution were found in both normal and diseased liver.
11.6. The novel description of type VI distribution.
No previous studies had examined the detailed 
distribution of type VI collagen in the human liver. Von 
der Mark ( 1984 ) reported the presence of type VI collagen 
in the liver but not the pattern of distribution. It has 
previously been regarded as one of the minor collagen 
components due to the relatively small amounts found in 
tissue. This study found a zonal heterogeneity of type VI 
collagen unlike the distribution of collagen types I and 
III (Griffiths et al, 1991). As mentioned in chapter 10 
this zonality was unlikely to be artefactual as other 
sections of the same tissue blocks were labelled for type I 
or III collagen and the distribution of these matrix 
components was homogeneous throughout the liver. Another 
possible explanation for the apparent zonal distribution 
was that type VI collagen was evenly distributed within the 
liver, but in zone 1 it was masked by other molecules such 
as glycosaminoglycans.
Evidence of functional heterogeneity within the liver 
has been demonstrated for a number of metabolic processes 
(Gumucio, 1989), and Martinez-Hernandez and Amenta have 
described alterations in the composition of the
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extracellular matrix across the acinus. Reid et al (1992) 
hypothesised that there were hepatic gradients for a number 
of hepatic extracellular matrix components and the type VI 
collagen distribution described above is consistent with 
this. In the area of the portal triad the matrix
consists of basement membrane components with fibrillar 
collagen. This alters as the central vein is approached, 
when the matrix consists of fibrillar collagens, 
fibronectin and proteoglycans. It is already acknowledged 
that the composition of the extracellular matrix can affect 
the function and gene expression of liver cells by binding 
to integrins in the cell membranes (Bucher et al, 1990), 
and the zonal distribution of the type VI collagen suggests 
a possible role for this extracellular matrix component in 
modulating the functional heterogeneity of the liver.
The ultrastructural study showed type VI collagen as a 
fine fibre which was intertwined between the larger 
striated fibres of the other interstitial collagens. This 
was consistent with Keene et al' s description of type VI 
collagen in skin using stereopair electron microscopy, when 
it appeared as a branching filamentous network surrounding 
interstitial collagen fibres. Type VI collagen may
therefore play an important role in organising the other 
components of the extracellular matrix. All striated
collagen fibres are individually synthesised and secreted 
from their cell of origin, but within the tissue they form 
compact and parallel bundles. It is the type VI collagen 
which is at least partially responsible for this 
organisation. In 1992, Loreal et al also described the
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presence of type VI collagen around bundles of striated 
collagen. They did not describe any zonal heterogeneity 
of distribution.
When the immunolabelling of type VI collagen was 
examined in acute liver injury or non-specific reactive 
changes the amount and distribution was essentially the 
same as in normal liver. In comparison, the amount was 
increased in fibrotic liver, even in precirrhotic 
conditions. The relatively large increase of this minor 
extracellular matrix component from the onset of fibrosis 
suggests that it may play an important role in 
fibrogenesis, particularly in the early stages. This is 
in agreement with the recent study by Loreal et al (1992), 
who also identified intracellular labelling for type VI 
collagen in fat-storing cells, using ultrastructural 
immunoperoxidase. In fibrotic liver increased amounts of 
type VI collagen were often associated with large areas of 
disordered striated collagen fibres. Such disordered 
areas are often an indication of newly synthesised collagen 
and type VI collagen may be synthesised in order to 
organise the fibres of collagen types I and III into their 
characteristic bundles, as seen in established cirrhosis.
11.7. The presence of a basement membrane in the space of 
Disse.
Basement membranes are found around the hepatic 
arteries, portal veins, lymphatic vessels, bile ducts and 
nerve axons (Vracko, 1982). Although in normal liver 
these basement membranes can be viewed by conventional
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electron microscopy, the space of Disse is unusual, in that 
individual components of the basement membrane have been 
identified immunocytochemically but no basement membrane is 
visible by electron microscopy (Griffiths et al, 1991). 
The formation of the basement membrane in the space of 
Disse (capillarization), often occurs during hepatic 
fibrosis (Schaffner and Popper, 1963). These are two
possible explanations for this. The first is that there is 
a functional membrane present at all times, but that the 
structure differs from other basement membranes i.e. it is 
more diffuse in normal tissue, and it thickens during 
capillarization. The second theory is that there is no 
membrane present in normal liver although the individual 
components are there, and that the membrane is only formed 
during capillarization. If this is the case, there may be 
one vital component of the membrane which is only produced 
during capillarization.
The results obtained from this study tend to support 
the second theory. The two major components of the
baement membrane, type IV collagen and laminin, are both 
present in normal liver, although in small guantities when 
compared to fibrotic liver. As there is no evidence of 
either a structural or a functional basement menbrane in 
normal liver it seems likely that at least one component is 
missing, and that this is produced during fibrosis. One 
molecule which has been suggested for this role is nidogen, 
also known as entactin (Ramadori et al,1991). It is
capable of binding to laminin and to type IV collagen, and 
it has been localised in the basement membrane of rat liver
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around bile ducts and blood vessels. It is not present 
sub-endothelially in normal liver.
Irrespective of the origin of the basement membrane 
found in fibrotic liver, it has a major effect on hepatic 
function. In normal liver, there is a ready flow of
plasma between sinusoids and hepatocytes. This is blocked 
in fibrotic liver and may contribute to the onset of portal 
hypertension, as well as contributing to disordered 
hepatocyte function by depriving the cells of oxygen and 
nutrients.
11.8. Cellular origin of extracellular matrix proteins
The identification of the cell types which actually 
synthesise the hepatic extracellular matrix has been the 
subject of debate for many years. Initial studies using 
cell culture techniques suggested that hepatocytes were a 
major source of collagen synthesis (Saber, Schafritz and 
Zern, 1983). This however was disputed by Maher et al
(1988) who believed that this could be explained by 
contamination of the cultures by fat-storing cells. In 
all cell culture studies there is the problem in that 
results from in vitro studies are directly applied to an in 
vivo situation, where the factors controlling extracellular 
matrix synthesis may be totally different.
In this study we attempted to use intracellular 
labelling in order to identify the cells which were 
responsible for extracellular matrix synthesis. 
Irrespective of the anti-extracellular matrix protein 
antibody used, significant amounts of intracellular
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staining were rarely observed. On the few occasions where
labelling did occur, it was always within the fat-storing
cells. This was consistent with the findings of other
groups which identified collagen either within (Kent et al, 
1976; Takahara et al, 1988 and Clement et al, 1988) or very 
closely associated with ( Grimaud et al, 1980) fat-storing 
cells. The possible reasons for the failure to detect the 
matrix proteins in an intracellular pattern are discussed 
in section 11.4. The next approach was to look at the 
cells which were immediately adjacent to the different 
matrix proteins. These proteins are normally deposited in 
the immediate vicinity of their synthesis and are not 
exported far from the cell of origin. When the
pericellular distribution of the individual matrix proteins 
were examined, they could all be identified around fat- 
storing cells. The only other occasion in which a cell 
was surrounded by matrix proteins was in some cases of 
alcoholic liver disease, where hepatocytes were surrounded 
by a layer of striated collagen (types I and III). This 
may indicate collagen synthesis by hepatocytes in fibrotic 
liver conditions. The other possible explanation is that 
the synthesis was due to nearby fat-storing cells. When 
thin sections of tissue are being examined, it is difficult 
to envisage the three-dimensional structure of the liver 
and it is always possible that the cell responsible for the 
synthesis of the extracellular matrix, and the matrix 
itself may not be present in the same section. This means 
that although the presence of collagen next to a particular 
cell indicates that there is a strong probability of that
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cell being the source of the collagen, it cannot be 
regarded as an absolute fact. This must be borne in mind 
when interpreting results from histological sections.
A new technique which has been successfully developed 
since the start of this study is that of in-situ 
hybridisation. Instead of antibodies, this uses a
molecular probe, which is a small piece of DNA or RNA 
complementary to the DNA or RNA of interest. The probe is 
labelled, (this can be with a radionucleotide, biotin or 
digoxygenin) and once the probe has bound and the label is 
developed, it can be detected on the section by light 
microscopy. This method identifies the cells which are 
producing the molecule. Preliminary work carried out in 
this department using digoxygenin-labelled RNA probes to 
type I collagen, indicated that it is the fat-storing cells 
which are responsible for type I collagen synthesis. This 
was true in both normal and CCl4-treated rat liver. In 
contrast to similar work by Yamada et al examining type III 
collagen in liver ( 1989), we did not find any evidence of 
collagen production in hepatocytes.
11.9. Liver as an ecosystem.
When the pattern of hepatic extracellular matrix 
synthesis is studied, it cannot be regarded in isolation. 
If the ability of hepatocytes to produce liver specific 
proteins is affected by the substrate which they are 
attached to, alterations in the pattern of extracellular 
matrix protein synthesis will lead to alterations in liver 
function (Bissell,1990). One such example is the
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capillarization of the space of Disse, in which the 
hepatocytes come into contact with newly synthesised 
basement membrane. This means that in addition to the 
consequences of isolating the hepatocytes from the plasma 
supply as discussed in chapter 11.7, the hepatocyte 
phenotype may be altered by the change in substrate.
This is one example of the balance within the liver, 
where cell-matrix and cell-cell interactions are equally 
important. In normal liver and during liver regeneration, 
there is a carefully maintained balance between all of the 
components of the extracellular matrix, and the cells 
within the liver. When this balance is lost i.e. during 
fibrosis, the liver is affected both structurally and 
functionally. It can be difficult, if not impossible to 
separate cause and effect, i.e. the formation of scar 
tissue may affect the function of adjacent cells which then 
alter their pattern of extracellular matrix synthesis and 
produce more fibrotic tissue. It can be difficult to 
distinguish this from scar tissue due to the primary 
injury of cells.
Another such example is the alteration during 
fibrosis of the ratio of type I to type III collagen, 
which decreases in the early stages of fibrosis, and 
increases later on. If each individual collagen type has 
a specific effect on parenchymal or non-parenchymal cells 
via a collagen specific receptor, then the altered ratio of 
the collagen types will have functional as well as 
structural implications. The receptors which could be
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important in this respect are likely to be part of the 
integrin family.
When these complex relationships are taken into 
consideration, the deposition of collagen and other 
extracellular matrix proteins cannot be regarded as a 
purely structural change, with any functional abnormalities 
such as the development of portal hypertension due to 
mechanical blockages.
Caution must also be used when examining alterations 
to one component of the hepatic extracellular matrix in 
liver disease. In many cases there is an increase in all 
components of the matrix and it is important to consider 
the extent of any increase in one component in relation to 
the others i.e. how is the overall ratio of the components 
affected? One such example is in type VI collagen. As 
this is one of the minor collagens the increase in 
cirrhotic liver is low when measured in terms of total
collagen (0.1% to 0.2% of total collagen), but this
represents a 100% increase in the amount of type VI 
collagen during cirrhosis. It is likely that this collagen 
plays an important role during fibrosis, as the amount of 
type VI collagen is increased, even in pre-cirrhotic 
stages.
Although we can identify fibrotic liver and identify 
the components of the extracellular matrix which are
present, the broad pattern is usually the same, 
irrespective of the original cause of injury. The only 
differences found are between chronic and acute liver 
injury, and in the area of the acinus where the injury
135
occurs. Irrespective of the cause of fibrosis, the
alterations in the extracellular matrix are essentially the 
same, indicating a common mechanism of fibrosis.
This means that if there are any differences in the 
extracellular matrix they are most likely to be 
identifiable at the ultrastructural level, where the tissue 
can be examined in detail and the individual collagen types 
can be identified. The techniques developed as part of 
this study will allow further study of the ultrastructural 
changes in hepatic fibrosis. These results will be of 
most use when examined in conjunction with results obtained 
by a range of other methods such as in situ hybridisation.
The extracellular matrix cannot be understood by 
examining a small number of its many and complex components 
in isolation. It is also true that one individual
technique cannot be used to reveal its secrets. The 
techniques which have been developed during this thesis, 
and the results which they have produced, may help to place 
a few more pieces in the complex (and three-dimensional) 
puzzle which is the hepatic extracellular matrix.
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APPENDIX A FIXATIVES
1. 0.2M phosphate buffer p.H. 7.4 
800ml 0.23M Na2HP042H20 solution A
250ml 0.2M KH2P04 solution B
Add solution B to solution A until the pH. reaches 7.4
2. 4% paraformaldehyde
Add paraformaldehyde (Fluka, Germany) to 0.2M phosphate 
buffer (final paraformaldehyde concentration of 4%) and heat 
to dissolve.
3. 2% paraformaldehyde
Mix equal volumes of 4% paraformaldehyde and 4% sucrose/H20.
4. 2% paraformaldehyde / 0.1% qlutaraldehyde.
Add 0.4ml of 25% glutaraldehyde (EM grade, Agar Aids, U.K.) 
to each 100 ml of 2% paraformaldehyde solution.
All fixatives were stored at -20°C after preparation,
although glutaraldehyde was not added until fixative was
required.
APPENDIX B RESIN EMBEDDING
1 . Sorensens 1 phosphate buffer pH 7.4 5 min
2 . Sorensens' buffer 5 min
3. 1% 0s04 in phosphate buffer pH 7.4 45 min
4. Sorensens' buffer 5 min
5. Sorensens' buffer 5 min
6 . 25% ethyl alcohol 10 min
7. 50% ethyl alcohol 10 min
8. 75% ethyl alcohol 20 min
9. 100% ethyl alcohol 20 min
10 .100% ethyl alcohol 20 min
11 .100% ethyl alcohol 20 min
12 .100% ethyl alcohol 10 min
13 .Propylene oxide 5 min
14 .Propylene oxide 10 min
15 .Araldite:propylene oxide 1:1 1 hr 40 min
16 .Araldite:propylene oxide 3:1 2 hours
17 .Araldite mix (60°C) overnight
Araldite mix 
Araldite resin (CY212) 
Dodecenylsuccinic anhydride (DDSA) 
DMP-30
2,4,6-tri(dimethylaminomethyl phenol) 
dibutyl phthalate
10 ml 
10 ml 
0.5 ml
1 ml
APPENDIX C
Staining resin embedded sections
1. Saturated uranyl acetate in 50% ethanol
(in dark) 10
2. Rinse with distilled H20
3. Blot dry
4. "Reynolds" lead citrate 1-2
5. Rinse
6. Blot dry
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